Pesticidal toxins

Description

BACKGROUND OF THE INVENTION
The soil microbe Bacillus thuringiensis (B.t.) is a Gram-positive, spore-forming bacterium characterized by parasporal crystalline protein inclusions. These inclusions often appear microscopically as distinctively shaped crystals. The proteins can be highly toxic to pests and specific in their toxic activity. Certain B.t. toxin genes have been isolated and sequenced, and recombinant DNA-based B.t. products have been produced and approved for use. In addition, with the use of genetic engineering techniques, new approaches for delivering these B.t. endotoxins to agricultural environments are under development, including the use of plants genetically engineered with endotoxin genes for insect resistance and the use of stabilized intact microbial cells as B.t. endotoxin delivery vehicles (Gaertner, F. H., L. Kim [1988] TIBTECH 6:S4-S7). Thus, isolated B.t. endotoxin genes are becoming commercially valuable.
Until the last ten years, commercial use of B.t. pesticides has been largely restricted to a narrow range of lepidopteran (caterpillar) pests. Preparations of the spores and crystals of B. thuringiensis subsp. kurstaki have been used for many years as commercial insecticides for lepidopteran pests. For example, B. thuringiensis var. kurstaki HD-1 produces a crystalline .delta.-endotoxin which is toxic to the larvae of a number of lepidopteran insects.
In recent years, however, investigators have discovered B.t. pesticides with specificities for a much broader range of pests. For example, other species of B.t., namely israelensis and tenebrionis (a.k.a. B.t. M-7, a.k.a. B.t. san diego), have been used commercially to control insects of the orders Diptera and Coleoptera, respectively (Gaertner, F. H. [1989] "Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms," in Controlled Delivery of Crop Protection Agents, R. M. Wilkins, ed., Taylor and Francis, New York and London, 1990, pp. 245-255). See also Couch, T. L. (1980) "Mosquito Pathogenicity of Bacillus thuringiensis var. israelensis," Developments in Industrial Microbiology 22:61-76; Beegle, C. C., (1978) "Use of Entomogenous Bacteria in Agroecosystems," Developments in Industrial Microbiology 20:97-104. Krieg, A., A. M. Huger, G. A. Langenbruch, W. Schnetter (1983) Z. ang. Ent. 96:500-508, describe Baccillus thuringiensis var. tenebrionis, which is reportedly active against two beetles in the order Coleoptera. These are the Colorado potato beetle, Leptinotarsa decemlineata, and Agelastica alni.
Recently, new subspecies of B.t. have been identified, and genes responsible for active .delta.-endotoxin proteins have been isolated (Hofte, H., H. R. Whiteley [1989] Microbiological Reviews 52(2):242-255). Hofte and Whiteley classified B.t. crystal protein genes into 4 major classes. The classes were CryI (Lepidoptera-specific), CryII (Lepidoptera- and Diptera-specific), CryIII (Coleoptera-specific), and CryIV (Diptera-specific). The discovery of strains specifically toxic to other pests has been reported. (Feitelson, J. S., J. Payne, L. Kim [1992] Bio/Technology 10:271-275).
The cloning and expression of a B.t. crystal protein gene in Escherichia coli has been described in the published literature (Schnepf, H. E., H. R. Whiteley [1981] Proc. Natl. Acad. Sci USA 78:2893-2897). U.S. Pat. No. 4,448,885 and U.S. Pat. No. 4,467,036 both disclose the expression of B.t. crystal protein in E. coli. U.S. Pat. Nos. 4,797,276 and 4,853,331 disclose B. thuringiensis strain tenebrionis (a.k.a. M-7, a.k.a. B.t. san diego) which can be used to control coleopteran pests in various environments. U.S. Pat. No. 4,918,006 discloses B.t. toxins having activity against Dipterans. U.S. Pat. No. 4,849,217 discloses B.t. isolates which have activity against the alfalfa weevil. U.S. Pat. No. 5,208,017 discloses coleopteran-active Bacillus thuringiensis isolates. U.S. Pat. No. 5,151,363 and U.S. Pat. No. 4,948,734 disclose certain isolates of B.t. which have activity against nematodes. As a result of extensive research and investment of resources, other patents have issued for new B.t. isolates and new uses of B.t. isolates. However, the discovery of new B.t. isolates and new uses of known B.t. isolates remains an empirical, unpredictable art.
Coleopterans are an important group of agricultural pests which cause a very large amount of damage each year. Examples of coleopteran pests include alfalfa weevils and corn rootworm.
The alfalfa weevil, Hypera postica, and the closely related Egyptian alfalfa weevil, Hypera brunneipennis, are the most important insect pests of alfalfa grown in the United States, with 2.9 million acres infested in 1984. An annual sum of 20 million dollars is spent to control these pests. The Egyptian alfalfa weevil is the predominant species in the southwestern U.S., where it undergoes aestivation (i.e., hibernation) during the hot summer months. In all other respects, it is identical to the alfalfa weevil, which predominates throughout the rest of the U.S.
The larval stage is the most damaging in the weevil life cycle. By feeding at the alfalfa plant's growing tips, the larvae cause skeletonization of leaves, stunting, reduced plant growth, and, ultimately, reductions in yield. Severe infestations can ruin an entire cutting of hay. The adults, also foliar feeders, cause additional, but less significant, damage.
Approximately 9.3 million acres of U.S. corn are infested with corn rootworm species complex each year. The corn rootworm species complex includes the northern corn rootworm, Diabrotica barberi, the southern corn rootworm, D. undecimpunctata howardi, and the western corn rootworm, D. virgifera virgifera. The soil-dwelling larvae of these Diabrotica species feed on the root of the corn plant, causing lodging. Lodging eventually reduces corn yield and often results in death of the plant. By feeding on cornsilks, the adult beetles reduce pollination and, therefore, detrimentally effect the yield of corn per plant. In addition, adults and larvae of the genus Diabrotica attack cucurbit crops (cucumbers, melons, squash, etc.) and many vegetable and field crops in commercial production as well as those being grown in home gardens.
Control of corn rootworm has been partially addressed by cultivation methods, such as crop rotation and the application of high nitrogen levels to stimulate the growth of an adventitious root system. However, chemical insecticides are relied upon most heavily to guarantee the desired level of control. Insecticides are either banded onto or incorporated into the soil. The major problem associated with the use of chemical insecticides is the development of resistance among the treated insect populations.
BRIEF SUMMARY OF THE INVENTION
The subject invention concerns novel materials and methods for controlling non-mammalian pests. In a preferred embodiment, the subject invention provides materials sand methods for the control of coleopteran pests. In specific embodiments, the materials and methods described herein are used to control alfalfa weevil and/or corn rootworm.
The subject invention advantageously provides two new classes of polynucleotide sequences which encode corresponding novel classes of pesticidal proteins. One novel class of polynucleotide sequences as described herein encodes toxins which have a full-length molecular weight of approximately 40-50 kDa. In a specific embodiment, these toxins have a molecular weight of about 43-47 kDa. A second class of polynucleotides, which encodes pesticidal proteins of about 10-15 kDa, is also provided according to the subject invention. In a specific embodiment, these toxins have a molecular weight of about 13-14 kDa. The subject invention concerns polynucleotides which encode the 40-50 kDa and 10-15 kDa toxins, polynucleotides which encode pesticidal fragments of the full length toxins, and polynucleotide sequences which encode longer forms of these toxins which include, for example, a protoxin region. In a preferred embodiment, these toxins, including the fragments, are active against coleopteran pests.
Specific B.t. toxins useful according to the invention include toxins which can be obtained from the B.t. isolates designated as PS80JJ1, PS149B1, and PS167H2. Of these, PS149B1 and PS167H2 are novel isolates. The subject invention also includes the use of variants of the exemplified B.t. isolates and toxins which have substantially the same coleopteran-active properties as the specifically exemplified B.t. isolates and toxins. Such variant isolates would include, for example, mutants. Procedures for making mutants are well known in the microbiological art. Ultraviolet light and chemical mutagens such as nitrosoguanidine are used extensively toward this end.
In one embodiment of the subject invention, the polynucleotide sequences of the subject invention are used to encode toxins of approximately 43-47 kDa. These toxins are then used to control coleopteran pests. In a particularly preferred embodiment, the coleopteran pests are corn rootworms. The genes which encode the 43-47 kDa toxins can be obtained from, for example, PS80JJ1, PS149B1, or PS167H2. In a second embodiment, toxins of approximately 13-14 kDa are used to control coleopteran pests. The approximately 13-14 kDa toxin, as well as the genes which encode these toxins, can also be obtained from PS80JJ1, PS149B1, or PS167H2. In a particularly preferred embodiment, the activity of the 43-47 kDa toxins can be augmented and/or facilitated by further contacting the target pests with an approximately 13-14 kDa toxin.
In a preferred embodiment, the subject invention concerns plants cells transformed with at least one polynucleotide sequence of the subject invention such that the transformed plant cells express pesticidal toxins in tissues consumed by the target pests.
Alternatively, the B.t. isolates of the subject invention, or recombinant microbes expressing the toxins described herein, can be used to control pests. In this regard, the invention includes the treatment of substantially intact B.t. cells, and/or recombinant cells containing the expressed toxins of the invention, treated to prolong the pesticidal activity when the substantially intact cells are applied to the environment of a target pest. The treated cell acts as a protective coating for the pesticidal toxin. The toxin becomes active upon ingestion by a target insect.

BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows three specific 43-47 kDa pesticidal toxins of the subject invention as well as a consensus sequence for these pesticidal toxins.
FIG. 2 shows the relationship of the 14 and 45 kDa sequences of PS80JJ1 (SEQ ID NOS. 31 and 10).

BRIEF DESCRIPTION OF THE SEQUENCES
SEQ ID NO. 1 is a 5-amino acid N-terminal sequence of the approximately 45 kDa toxin of 80JJ1.
SEQ ID NO. 2 is a 25-amino acid N-terminal sequence of the approximately 45 kDa toxin of 80JJ1.
SEQ ID NO. 3 is a 24-amino acid N-terminal sequence of the approximately 14 kDa toxin of 80JJ1.
SEQ ID NO. 4 is the N-terminal sequence of the approximately 47 kDa toxin from 149B1.
SEQ ID NO. 5 is a 50-amino acid N-terminal amino acid sequence for the purified approximately 14 kDa protein from PS149B1.
SEQ ID NO. 6 is the N-terminal sequence of the approximately 47 kDa toxin from 167H2.
SEQ ID NO. 7 is a 25-amino acid N-terminal sequence for the purified approximately 14 kDa protein from PS167H2.
SEQ ID NO. 8 is an oligonucleotide probe for the gene encoding the PS80JJ1 44.3 kDa toxin and is a forward primer for PS149B1 and PS167H2 used according to the subject invention.
SEQ ID NO. 9 is a reverse primer for PS149B1 and PS167H2 used according to the subject invention.
SEQ ID NO. 10 is the nucleotide sequence of the gene encoding the approximately 45 kDa PS80JJ1 toxin.
SEQ ID NO. 11 is the amino acid sequence for the approximately 45 kDa PS80JJ1 toxin.
SEQ ID NO. 12 is the partial nucleotide sequence of the gene encoding the approximately 44 kDa PS149B1 toxin.
SEQ ID NO. 13 is the partial amino acid sequence for the approximately 44 kDa PS149B1 toxin.
SEQ ID NO. 14 is the partial nucleotide sequence of the gene encoding the approximately 44 kDa PS167H2 toxin.
SEQ ID NO. 15 is the partial amino acid sequence for the approximately 44 kDa PS167H2 toxin.
SEQ ID NO. 16 is a peptide sequence used in primer design according to the subject invention.
SEQ ID NO. 17 is a peptide sequence used in primer design according to the subject invention.
SEQ ID NO. 18 is a peptide sequence used in primer design according to the subject invention.
SEQ ID NO. 19 is a peptide sequence used in primer design according to the subject invention.
SEQ ID NO. 20 is a nucleotide sequence corresponding to the peptide of SEQ ID NO. 16.
SEQ ID NO. 21 is a nucleotide sequence corresponding to the peptide of SEQ ID NO. 17.
SEQ ID NO. 22 is a nucleotide sequence corresponding to the peptide of SEQ ID NO. 18.
SEQ ID NO. 23 is a nucleotide sequence corresponding to the peptide of SEQ ID NO. 19.
SEQ ID NO. 24 is a reverse primer based on the reverse complement of SEQ ID NO. 22.
SEQ ID NO. 25 is a reverse primer based on the reverse complement of SEQ ID NO. 23.
SEQ ID NO. 26 is a forward primer based on the PS80JJ1 44.3 kDa toxin.
SEQ ID NO. 27 is a reverse primer based on the PS80JJ1 44.3 kDa toxin.
SEQ ID NO. 28 is a generic sequence representing a new class of toxins according to the subject invention.
SEQ ID NO. 19 is an oligonucleotide probe used according to the subject invention.
SEQ ID NO. 30 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 45 kDa PS80JJ1 toxins and the flanking nucleotide sequences.
SEQ ID NO. 31 is the nucleotide sequence of the PS80JJ1 14 kDa toxin open reading frame.
SEQ ID NO. 32 is the deduced amino acid sequence of the 14 kDa toxin of PS80JJ1.
SEQ ID NO. 33 is a reverse oligonucleotide primer used according to the subject invention.
SEQ ID NO. 34 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 44 kDa PS167H2 toxins and the flanking nucleotide sequences.
SEQ ID NO. 35 is the nucleotide sequence of the gene encoding the approximately 14 kDa PS167H2 toxin.
SEQ ID NO. 36 is the amino acid sequence for the approximately 14 kDa PS167H2 toxin.
SEQ ID NO. 37 is the nucleotide sequence of the gene encoding the approximately 44 kDa PS167H2 toxin.
SEQ ID NO. 38 is the amino acid sequence for the approximately 44 kDa PS167H2 toxin.
SEQ ID NO. 39 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 44 kDa PS149B1 toxins and the flanking nucleotide sequences.
SEQ ID NO. 40 is the nucleotide sequence of the gene encoding the approximately 14 kDa PS149B1 toxin.
SEQ ID NO. 41 is the amino acid sequence for the approximately 14 kDa PS149B1 toxin.
SEQ ID NO. 42 is the nucleotide sequence of the gene encoding the approximately 44 kDa PS149B1 toxin.
SEQ ID NO. 43 is the amino acid sequence for the approximately 44 kDa PS149B1 toxin.
SEQ ID NO. 44 is a maize-optimized gene sequence encoding the approximately 14 kDa toxin of 80JJ1.
SEQ ID NO. 45 is a maize-optimized gene sequence encoding the approximately 44 kDa toxin of 80JJ1.
DETAILED DISCLOSURE OF THE INVENTION
The subject invention concerns two new classes of polynucleotide sequences which encode novel pesticidal toxins. In one embodiment, the toxins have a full-length molecular weight of approximately 40-50 kDa. In specific embodiments exemplified herein, these toxins have a molecular weight of about 43-47 kDa. In a second embodiment, the pesticidal toxins have a molecular weight of approximately 10-15 kDa. In specific embodiments exemplified herein, these toxins have a molecular weight of about 13-14 kDa. Certain specific toxins are exemplified herein. For toxins having a known amino acid sequence, the molecular weight is also known. Those skilled in the art will recognize that the apparent molecular weight of a protein as determined by gel electrophoresis will sometimes differ from the true molecular weight. Therefore, reference herein to, for example, a 45 kDa protein or a 14 kDa protein is understood to refer to proteins of approximately that size even if the true molecular weight is somewhat different.
The subject invention concerns not only the polynucleotide sequences which encode these classes of toxins, but also the use of these polynucleotide sequences to produce recombinant hosts which express the toxins. In a further aspect, the subject invention concerns the combined use of an approximately 40-50 kDa toxin of the subject invention together with an approximately 10-15 kDa toxin of the subject invention to achieve highly effective control of pests, including coleopterans such as corn rootworm.
A further aspect of the subject invention concerns two novel isolates and the toxins and genes obtainable from these isolates. The novel B.t. isolates of the subject invention have been designated PS149B1 and PS167H2.
The new classes of toxins and polynucleotide sequences provided here are defined according to several parameters. One critical characteristic of the toxins described herein is pesticidal activity. In a specific embodiment, these toxins have activity against coleopteran pests. The toxins and genes of the subject invention can be further defined by their amino acid and nucleotide sequences. The sequences of the molecules within each novel class can be defined herein in terms of homology to certain exemplified sequences as well as in terms of the ability to hybridize with, or be amplified by, certain exemplified probes and primers. The classes of toxins provided herein can also be identified based on their immunoreactivity with certain antibodies and based upon their adherence to a generic formula.
The sequence of three approximately 45 kDa toxins of the subject invention are provided as SEQ ID NOS. 11, 43, and 38. In a preferred embodiment of the subject invention, the toxins in this new class have a sequence which conforms to the generic sequence presented as SEQ ID NO. 28. In a specific embodiment, the toxins of this class will conform to the consensus sequence shown in FIG. 1.
In a preferred embodiment, the toxins of the subject invention have at least one of the following characteristics:
(a) said toxin is encoded by a nucleotide sequence which hybridizes under stringent conditions with a nucleotide sequence selected from the group consisting of: DNA which encodes SEQ ID NO. 2, DNA which encodes SEQ ID NO. 4, DNA which encodes SEQ ID NO. 6, SEQ ID NO. 8, SEQ ID NO. 10, DNA which encodes SEQ ID NO. 11, SEQ ID NO. 12, DNA which encodes SEQ ID NO. 13, SEQ ID NO. 14, DNA which encodes SEQ ID NO. 15, DNA which encodes SEQ ID NO. 16, DNA which encodes SEQ ID NO. 17, DNA which encodes SEQ ID NO. 18, DNA which encodes SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, DNA which encodes a pesticidal portion of SEQ ID NO. 28, SEQ ID NO. 37, DNA which encodes SEQ ID NO. 38, SEQ ID NO. 42, and DNA which encodes SEQ ID NO. 43;
(b) said toxin immunoreacts with an antibody to an approximately 40-50 kDa pesticidal toxin, or a fragment thereof, from a Bacillus thuringiensis isolate selected from the group consisting of PS80JJ1 having the identifying characteristics of NRRL B-18679, PS149B1 having the identifying characteristics of NRRL B-21553, and PS167H2 having the identifying characteristics of NRRL B-21554;
(c) said toxin is encoded by a nucleotide sequence wherein a portion of said nucleotide sequence can be amplified by PCR using a primer pair selected from the group consisting of SEQ ID NOS. 20 and 24 to produce a fragment of about 495 bp, SEQ ID NOS. 20 and 25 to produce a fragment of about 594 bp, SEQ ID NOS. 21 and 24 to produce a fragment of about 471 bp, and SEQ ID NOS. 21 and 25 to produce a fragment of about 580 bp;
(d) said toxin comprises a pesticidal portion of the amino acid sequence shown in SEQ ID NO. 28;
(e) said toxin comprises an amino acid sequence which has at least about 60% homology with a pesticidal portion of an amino acid sequence selected from the group consisting of SEQ ID NO. 11, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 38, and SEQ ID NO. 43;
(f) said toxin is encoded by a nucleotide sequence which hybridizes under stringent conditions with a nucleotide sequence selected from the group consisting of DNA which encodes SEQ ID NO. 3, DNA which encodes SEQ ID NO. 5, DNA which encodes SEQ ID NO. 7, DNA which encodes SEQ ID NO. 32, DNA which encodes SEQ ID NO. 36, and DNA which encodes SEQ ID NO. 41;
(g) said toxin immunoreacts with an antibody to an approximately 10-15 kDa pesticidal toxin, or a fragment thereof, from a Bacillus thuringiensis isolate selected from the group consisting of PS80JJ1 having the identifying characteristics of NRRL B-18679, PS149B1 having the identifying characteristics of NRRL B-21553, and PS167H2 having the identifying characteristics of NRRL B-21554;
(h) said toxin is encoded by a nucleotide sequence wherein a portion of said nucleotide sequence can be amplified by PCR using the primer pair of SEQ ID NO. 29 and SEQ ID NO. 33; and
(i) said toxin comprises an amino acid sequence which has at least about 60% homology with an amino acid sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 5, SEQ ID NO. 7, pesticidal portions of SEQ ID NO. 32, pesticidal portions of SEQ ID NO. 36, and pesticidal portions of SEQ ID NO. 41.
As used herein "stringent" conditions for hybridization refers to conditions which achieve the same, or about the same, degree of specificity of hybridization as the conditions employed by the current applicants. Specifically, hybridization of immobilized DNA on Southern blots with 32P-labeled gene-specific probes was performed by standard methods (Maniatis, T., E. F. Fritsch, J. Sambrook [1982] Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.). In general, hybridization and subsequent washes were carried out under stringent conditions that allowed for detection of target sequences with homology to the PS80JJ1 toxin genes. For double-stranded DNA gene probes, hybidization was carried out overnight at 20-25.degree. C. below the melting temperature (Tm) of the DNA hybrid in 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. The melting temperature is described by the following formula (Beltz, G. A., K. A. Jacobs, T. H. Eickbush, P. T. Cherbas, and F. C. Kafatos [1983] Methods of Enzymology, R. Wu., L. Grossman and K. Moldave [eds.] Academic Press, New York 100:266-285).
Tm=81.5.degree. C.+16.6 Log[Na+]+0.41(% G+C)-0.61(% formamide)-600/length of duplex in base pairs.
Washes are typically carried out as follows:
(1) Twice at room temperature for 15 minutes in 1X SSPE, 0.1% SDS (low stringency wash).
(2) Once at Tm-20.degree. C. for 15 minutes in 0.2X SSPE, 0.1% SDS (moderate stringency wash).
For oligonucleotide probes, hybridization was carried out overnight at 10-20.degree. C. below the melting temperature (Tm) of the hybrid in 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. Tm for oligonucleotide probes was determined by the following formula:
Tm(.degree.C.)=2(number T/A base pairs)+4(number G/C base pairs)
(Suggs, S. V., T. Miyake, E. H. Kawashime, M. J. Johnson, K. Itakura, and R. B. Wallace [1981] ICN-UCLA Symp. Dev. Biol. Using Purified Genes, D. D. Brown [ed.], Academic Press, New York, 23:683-693).
Washes were typically carried out as follows:
(1) Twice at room temperature for 15 minutes 1X SSPE, 0.1% SDS (low stringency wash).
(2) Once at the hybridization temperature for 15 minutes in 1X SSPE, 0.1% SDS (moderate stringency wash).
With the teachings provided herein, one skilled in the art could readily produce and use the various toxins and polynucleotide sequences of the novel classes described herein.
Microorganisms useful according to the subject invention have been deposited in the permanent collection of the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Ill. 61604, USA. The culture repository numbers of the deposited strains are as follows:
______________________________________Culture Repository No. Deposit Date______________________________________B.t. strain PS80JJ1 NRRL B-18679 July 17, 1990 B.t. strain PS149B1 NRRL B-21553 March 28, 1996 B.t strain PS167H2 NRRL B-21554 March 28, 1996 E. coli NM522 (pMYC2365) NRRL B-21170 January 5, 1994 E. coli NM522 (pMYC2382) NRRL B-21329 September 28, 1994 E. coli NM522 (pMYC2379) NRRL B-21155 November 3, 1993 E. coli NM522 (pMYC2421) NRRL B-21555 March 28, 1996 E. coli NM522 (pMYC2427) NRRL B-21672 March 26, 1997 E. coli NM522 (pMYC2429) NRRL B-21673 March 26, 1997 E. coli NM522 (pMYC2426) NRRL B-21671 March 26, 1997______________________________________
The PS80JJ1 isolate is available to the public by virtue of the issuance of the U.S. Pat. No. 5,151,363.
B.t. isolates PS149B1 and PS167H2 have been deposited under conditions that assure that access to the cultures will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CRF 1.14 and 35 U.S.C. 122. The deposits are available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.
Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i.e., they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of a deposit, and in any case, for a period of at least 30 (thirty) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the cultures. The depositor acknowledges the duty to replace the deposit(s) should the depository be unable to furnish a sample when requested, due to the condition of the deposit(s). All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them.
Following is a table which provides characteristics of certain B.t. isolates useful according to the subject invention.
TABLE 1______________________________________Description of B.t. strains toxic to coleopterans Approx. Crystal MW NRRL Deposit Culture Description (kDa) Serotype Deposit Date______________________________________PS80JJ1 multiple 130, 90, 4a4b, sotto B-18679 7-17-90 attached 47, 37, 14 PS149B1 130, 47, B-21553 3-28-96 14 PS167H2 70, 47, 14 B-23554 3-28-96______________________________________
Genes and Toxins
The genes and toxins useful according to the subject invention include not only the full length sequences disclosed but also fragments of these sequences, variants, mutants, and fusion proteins which retain the characteristic pesticidal activity of the toxins specifically exemplified herein. As used herein, the terms "variants" or "variations" of genes refer to nucleotide sequences which encode the same toxins or which encode equivalent toxins having pesticidal activity. As used herein, the term "equivalent toxins" refers to toxins having the same or essentially the same biological activity against the target pests as the claimed toxins.
It should be apparent to a person skilled in this art that genes encoding active toxins can be identified and obtained through several means. The specific genes exemplified herein may be obtained from the isolates deposited at a culture depository as described above. These genes, or portions or variants thereof, may also be constructed synthetically, for example, by use of a gene synthesizer. Variations of genes may be readily constructed using standard techniques for making point mutations. Also, fragments of these genes can be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as Bal31 or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, genes which encode active fragments may be obtained using a variety of restriction enzymes. Proteases may be used to directly obtain active fragments of these toxins.
Equivalent toxins and/or genes encoding these equivalent toxins can be derived from B.t. isolates and/or DNA libraries using the teachings provided herein. There are a number of methods for obtaining the pesticidal toxins of the instant invention. For example, antibodies to the pesticidal toxins disclosed and claimed herein can be used to identify and isolate other toxins from a mixture of proteins. Specifically, antibodies may be raised to the portions of the toxins which are most constant and most distinct from other B.t. toxins. These antibodies can then be used to specifically identify equivalent toxins with the characteristic activity by immunoprecipitation, enzyme linked immunosorbent assay (ELISA), or western blotting. Antibodies to the toxins disclosed herein, or to equivalent toxins, or fragments of these toxins, can readily be prepared using standard procedures in this art. The gene which encode these toxins can then be obtained from the microorganism.
Fragments and equivalents which retain the pesticidal activity of the exemplified toxins would be within the scope of the subject invention. Also, because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. These variant DNA sequences are within the scope of the subject invention. As used herein, reference to "essentially the same" sequence refers to sequences which have amino acid substitutions, deletions, additions, or insertions which do not materially affect pesticidal activity. Fragments retaining pesticidal activity are also included in this definition.
A further method for identifying the toxins and genes of the subject invention is through the use of oligonucleotide probes. These probes are detectable nucleotide sequences. These sequences may be detectable by virtue of an appropriate label or may be made inherently fluorescent as described in International Application No. WO93/16094. As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming a strong bond between the two molecules, it can be reasonably assumed that the probe and sample have substantial homology. Preferably, hybridization is conducted under stringent conditions by techniques well-known in the art, as described, for example, in Keller, G. H., M. M. Manak (1987) DNA Probes, Stockton Press, New York, N.Y., pp. 169-170. Detection of the probe provides a means for determining in a known manner whether hybridization has occurred. Such a probe analysis provides a rapid method for identifying toxin-encoding genes of the subject invention. The nucleotide segments which are used as probes according to the invention can be synthesized using a DNA synthesizer and standard procedures. These nucleotide sequences can also be used as PCR primers to amplify genes of the subject invention.
Certain toxins of the subject invention have been specifically exemplified herein. Since these toxins are merely exemplary of the toxins of the subject invention, it should be readily apparent that the subject invention comprises variant or equivalent toxins (and nucleotide sequences coding for equivalent toxins) having the same or similar pesticidal activity of the exemplified toxins. Equivalent toxins will have amino acid homology with an exemplified toxin. The amino acid identify will typically be greater than 60%, preferably be greater than 75%, more preferably greater than 80%, more preferably greater than 90%, and can be greater than 95%. The amino acid homology will be highest in critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity. In this regard, certain amino acid substitutions are acceptable and can be expected if these substitutions are in regions which are not critical to activity or are conservative amino acid substitutions which do not affect the three-dimensional configuration of the molecule. For example, amino acids may be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type fall within the scope of the subject invention so long as the substitution does not materially alter the biological activity of the compound. Table 2 provides a listing of examples of amino acids belonging to each class.
TABLE 2______________________________________Class of Amino Acid Examples of Amino Acids______________________________________Nonpolar Ala, Val, Leu, Ile, Pro, Met, Phe, Trp Uncharged Polar Gly, Ser, Thr, Cys, Tyr, Asn, Gln Acidic Asp, Glu Basic Lys, Arg, His______________________________________
In some instances, non-conservative substitutions can also be made. The critical factor is that these substitutions must not significantly detract from the biological activity of the toxin.
The toxins of the subject invention can also be characterized in terms of the shape and locations of toxin inclusions, which are described above.
Recombinant Hosts
The toxin-encoding genes harbored by the isolates of the subject invention can be introduced into a wide variety of microbial or plant hosts. Expression of the toxin gene results, directly or indirectly, in the intracellular production and maintenance of the pesticide. With suitable microbial hosts, e.g., Pseudomonas, the microbes can be applied to the situs of the pest, where they will proliferate and be ingested. The result is a control of the pest. Alternatively, the microbe hosting the toxin gene can be treated under conditions that prolong the activity of the toxin and stabilize the cell. The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest.
Where the B.t. toxin gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, it is essential that certain host microbes be used. Microorganism hosts are selected which are known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere, and/or rhizoplane) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation.
A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide variety of important crops. These microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., genera Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g., genera Saccharomyces, Cryptococcus, Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacterium tumefaciens, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, and Azotobacter vinlandii; and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces roseus, S. odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms.
A wide variety of ways are available for introducing a B.t. gene encoding a toxin into a microorganism host under conditions which allow for stable maintenance and expression of the gene. These methods are well known to those skilled in the art and are described, for example, in U.S. Pat. No. 5,135,867, which is incorporated herein by reference.
Control of coleopterans, including corn rootworm using the isolates, toxins, and genes of the subject invention can be accomplished by a variety of methods known to those skilled in the art. These methods include, for example, the application of B.t. isolates to the pests (or their location), the application of recombinant microbes to the pests (or their locations), and the transformation of plants with genes which encode the pesticidal toxins of the subject invention. Recombinant microbes may be, for example, a B.t., E. coli, or Pseudomonas. Transformations can be made by those skilled in the art using standard techniques. Materials necessary for these transformations are disclosed herein or are otherwise readily available to the skilled artisan.
Synthetic genes which are functionally equivalent to the toxins of the subject invention can also be used to transform hosts. Methods for the production of synthetic genes can be found in, for example, U.S. Pat. No. 5,380,831.
Control of other pests such as lepidopterans and other insects, nematodes, and mites can also be accomplished by those skilled in the art using standard techniques combined with the teachings provided herein.
Treatment of Cells
As mentioned above, B.t. or recombinant cells expressing a B.t. toxin can be treated to prolong the toxin activity and stabilize the cell. The pesticide microcapsule that is formed comprises the B.t. toxin within a cellular structure that has been stabilized and will protect the toxin when the microcapsule is applied to the environment of the target pest. Suitable host cells may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals. However, organisms which produce substances toxic to higher organisms could be used, where the toxic substances are unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi.
The cell will usually be intact and be substantially in the proliferative form when treated, rather than in a spore form, although in some instances spores may be employed.
Treatment of the microbial cell, e.g., a microbe containing the B.t. toxin gene, can be by chemical or physical means, or by a combination of chemical and/or physical means, so long as the technique does not deleteriously affect the properties of the toxin, nor diminish the cellular capability of protecting the toxin. Examples of chemical reagents are halogenating agents, particularly halogens of atomic no. 17-80. More particularly, iodine can be used under mild conditions and for sufficient time to achieve the desired results. Other suitable techniques include treatment with aldehydes, such as glutaraldehyde; anti-infectives, such as zephiran chloride and cetylpyridinium chloride; alcohols, such as isopropyl and ethanol; various histologic fixatives, such as Lugol iodine, Bouin's fixative, various acids and Helly's fixative (See: Humason, Gretchen L., Animal Tissue Techniques, W.H. Freeman and Company, 1967); or a combination of physical (heat) and chemical agents that preserve and prolong the activity of the toxin produced in the cell when the cell is administered to the host environment. Examples of physical means are short wavelength radiation such as gamma-radiation and X-radiation, freezing, UV irradiation, lyophilization, and the like. Methods for treatment of microbial cells are disclosed in U.S. Pat. No. 4,695,455 and 4,695,462, which are incorporated herein by reference.
The cells generally will have enhanced structural stability which will enhance resistance to environmental conditions. Where the pesticide is in a proform, the method of cell treatment should be selected so as not to inhibit processing of the proform to the mature form of the pesticide by the target pest pathogen. For example, formaldehyde will crosslink proteins and could inhibit processing of the proform of a polypeptide pesticide. The method of treatment should retain at least a substantial portion of the bioavailability or bioactivity of the toxin.
Characteristics of particular interest in selecting a host cell for purposes of production include ease of introducing the B.t. gene into the host, availability of expression systems, efficiency of expression, stability of the pesticide in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; survival in aqueous environments; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handlink, economics, storage stability, and the like.
Growth of Cells
The cellular host containing the B.t. insecticidal gene may be grown in any convenient nutrient medium, where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the B.t. gene. These cells may then be harvested in accordance with conventional ways. Alternatively, the cells can be treated prior to harvesting.
The B.t. cells of the invention can be cultured using standard art media and fermentation techniques. Upon completion of the fermentation cycle the bacteria can be harvested by first separating the B.t. spores and crystals from the fermentation broth by means well known in the art. The recovered B.t. spores and crystals can be formulated into a wettable powder, liquid concentrage, granules or other formulations by the addition of surfactants, dispersants, inert carriers, and other components to facilitate handling and application for particular target pests. These formulations and application procedures are all well known in the art.
Formulations
Formulated bait granules containing an attractant and spores and crystals of the B.t. isolates, or recombinant microbes comprising the genes obtainable from the B.t. isolates disclosed herein, can be applied to the soil. Formulated product can also be applied as a seed-coating or root treatment or total plant treatment at later stages of the crop cycle. Plant and soil treatments of B.t. cells may be employed as wettable powders, granules or dusts, by mixing with various inert materials, such as inorganic minerals (phyllosilicates, carbonates, sulfates, phosphates, and the like) or botanical materials (powdered corncobs, rice hulls, walnut shells, and the like). The formulations may include spreader-sticker adjuvants, stabilizing agents, other pesticidal additives, or surfactants. Liquid formulations may be aqueous-based or non-aqueous and employed as foams, gels, suspensions, emulsifiable concentrates, or the like. The ingredients may include rehological agents, surfactants, emulsifiers, dispersants, or polymers.
As would be appreciated by a person skilled in the art, the pesticidal concentration will vary widely depending upon the nature of the particular formulation, particularly whether it is a concentrate or to be used directly. The pesticide will be present in at least 1% by weight and may be 100% by weight. The dry formulations will have from about 1-95% by weight of the pesticide while the liquid formulations will generally be from about 1-60% by weight of the solids in the liquid phase. The formulations will generally have from about 10.sup.2 to about 10.sup.4 cells/mg. These formulations will be administered at about 50 mg (liquid or dry) to 1 kg or more per hectare.
The formulations can be applied to the environment of the pest, e.g., soil and foliage, by spraying, dusting, sprinkling, or the like.
Mutants
Mutants of the isolates of the invention can be made by procedures well known in the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate (EMS) mutagenesis of an isolate. The mutants can be made using ultraviolet light and nitrosoguanidine by procedures well known in the art.
A smaller percentage of the asporogenous mutants will remain intact and not lyse for extended fermentation periods; these strains are designated lysis minus (-). Lysis minus strains can be identified by screening asporogenous mutants in shake flask media and selecting those mutants that are still intact and contain toxin crystals at the end of the fermentation. Lysis minus strains are suitable for a cell treatment process that will yield a protected, encapsulated toxin protein.
To prepare a phage resistant variant of said asporogenous mutant, an aliquot of the phage lysate is spread onto nutrient agar and allowed to dry. An aliquot of the phage sensitive bacterial strain is then plated directly over the dried lysate and allowed to dry. The plates are incubated at 30.degree. C. The plates are incubated for 2 days and, at that time, numerous colonies could be seen growing on the agar. Some of these colonies are picked and subcultured onto nutrient agar plates. These apparent resistant cultures are tested for resistance by cross streaking with the phage lysate. A line of the phage lysate is streaked on the plate and allowed to dry. The presumptive resistant cultures are then streaked across the phage line. Resistant bacterial cultures show no lysis anywhere in the streak across the phage line after overnight incubation at 30.degree. C. The resistance to phage is then reconfirmed by plating a lawn of the resistant culture onto a nutrient agar plate. The sensitive strain is also plated in the same manner to serve as the positive control. After drying, a drop of the phage lysate is placed in the center of the plate and allowed to dry. Resistant cultures showed no lysis in the area where the phage lysate has been placed after incubation at 30.degree. C. for 24 hours.
Following are examples which illustrate procedures for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.
EXAMPLE 1
Culturing of B.t. Isolates of the Invention
A subculture of the B.t. isolates, or mutants thereof, can be used to inoculate the following medium, a peptone, glucose, salts medium.
______________________________________Bacto Peptone 7.5 g/l Glucose 1.0 g/l KH.sub.2 PO.sub.4 3.4 g/l K.sub.2 HPO.sub.4 4.35 g/l Salt Solution 5.0 ml/l CaCl.sub.2 Solution 5.0 ml/l pH 7.2 Salts Solution (100 ml) MgSO.sub.4 .multidot.7H.sub.2 O 2.46 g MnSO.sub.4 .multidot.H.sub.2 O 0.04 g ZnSO.sub.4 .multidot.7H.sub.2 O 0.28 g FeSO.sub.4 .multidot.7H.sub.2 O 0.40 g CaCl.sub.2 Solution (100 ml) CaCl.sub.2 .multidot.H.sub.2 O 3.66 g______________________________________
The salts solution and CaCl.sub.2 solution are filter-sterilized and added to the autoclaved and cooked broth at the time of inoculation. Flasks are incubated at 30.degree. C. on a rotary shaker at 200 rpm for 64 hr.
The above procedure can be readily scaled up to large fermentors by procedures well known in the art.
The B.t. spores and/or crystals, obtained in the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centrifugation.
EXAMPLE 2
Protein Purification for 45 kDa 80JJ1 Protein
One gram of lyophilized powder of 80JJ1 was suspended in 40 ml of buffer containing 80 mM Tris-Cl pH 7.8, 5 mM EDTA, 100 .mu.M PMSF, 0.5 .mu.g/ml Leupeptin, 0.7 .mu.g/ml Pepstatin, and 40 .mu.g/ml Bestatin. The suspension was centrifuged, and the resulting supernatant was discarded. The pellet was washed five times using 35-40 ml of the above buffer for each wash. The washed pellet was resuspended in 10 ml of 40% NaBr, 5 mM EDTA, 100 .mu.M PMSF, 0.5 .mu.g/ml Leupeptin, 0.7 .mu.g/ml Pepstatin, and 40 .mu.g/ml Bestatin and placed on a rocker platform for 75 minutes. The NaBr suspension was centrifuged, the supernatant was removed, and the pellet was treated a second time with 40% NaBr, 5 mM EDTA, 100 .mu.M PMSF, 0.5 .mu.g/ml Leupeptin, 0.7 .mu.g/ml Pepstatin, and 40 .mu.g/ml Bestatin as above. The supernatants (40% NaBr soluble) were combined and dialyzed against 10 mM CAPS pH 10.0, 1 mM EDTA at 4.degree. C. The dialyzed extracts were centrifuged and the resulting supernatant was removed. The pellet (40% NaBr dialysis pellet) was suspended in 5 ml of H.sub.2 O and centrifuged. The resultant supernatant was removed and discarded. The washed pellet was washed a second time in 10 ml of H.sub.2 O and centrifuged as above. The washed pellet was suspended in 1.5 ml of H.sub.2 O and contained primarily three peptides with molecular weights of approximately 47 kDa, 45 kDa, and 15 kDa when analyzed using SDS-PAGE. At this stage of purification, the suspended 40% NaBr dialysis pellet contained approximately 21 mg/ml of protein by Lowry assay.
The peptides in the pellet suspension were separated using SDS-PAGE (Laemlli, U.K. [1970] Nature 227:680) in 15% acrylamide gels. The separated proteins were then electrophoretically blotted to a PVDF membrane (Millipore Corp.) in 10 mM CAPS pH 11.0, 10% MeOH at 100 V constant. After one hour the PVDF membrane was rinsed in water briefly and placed for 3 minutes in 0.25% Coomassie blue R-250, 50% methanol, 5% acetic acid. The stained membrane was destained in 40% MeOH, 5% acetic acid. The destained membrane was air-dried at room temperature (LeGendre et al. [1989] In A practical Guide to Protein Purification For Microsequencing, P. Matsudaira, ed. Academic Press, New York, N.Y.). The membrane was sequenced using automated gas phase Edman degradation (Hunkapillar, M. W., R. M. Hewick, W. L. Dreyer, L. E. Hood [1983] Meth. Enzymol. 91:399).
The amino acid analysis revealed that the N-terminal sequence of the 45 kDa band was as follows: Met-Leu-Asp-Thr-Asn (SEQ ID NO. 1).
The 47 kDa band was also analyzed and the N-terminal amino acid sequence was determined to be the same 5-amino acid sequence as SEQ ID NO. 1. Therefore, the N-terminal amino acid sequences of the 47 kDa peptide and the 45 kDa peptide were identical.
This amino acid sequence also corresponds to a sequence obtained from a 45 kDa peptide obtained from PS80JJ1 spore/crystal powders, using another purification protocol, with the N-terminal sequence as follows: Met-Leu-Asp-Thr-Asn-Lys-Val-Tyr-Glu-Ile-Ser-Asn-Leu-Ala-Asn-Gly-Leu-Tyr-Thr-Ser-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO. 2).
EXAMPLE 3
Purification of the 14 kDa Peptide of PS80JJ1
0.8 ml of the white dialysis suspension (approximately 21 mg/ml) containing the 47 kDa, 45 kDa, and 15 kDa peptides, was dissolved in 10 ml of 40% NaBr, and 0.5 ml of 100 mM EDTA were added. After about 18 hours (overnight), a white opaque suspension was obtained. This was collected by centrifugation and discarded. The supernatant was concentrated in a Centricon-30 (Amicon Corporation) to a final volume of approximately 15 ml. The filtered volume was washed with water by filter dialysis and incubated on ice, eventually forming a milky white suspension. The suspension was centrifuged and the pellet and supernatant were separated and retained. The pellet was then suspended in 1.0 ml water (approximately 6 mg/ml). The pellet contained substantially pure 15 kDa protein when analyzed by SDS-PAGE.
The N-terminal amino acid sequence was determined to be: Ser-Ala-Arg-Glu-Val-His-Ile-Glu-Ile-Asn-Asn-Thr-Arg-His-Thr-Leu-Gln-Leu-Glu-Ala-Lys-Thr-Lys-Leu (SEQ ID NO. 3).
EXAMPLE 4
Protein Purification and Characterization of PS149B1 45 kDa Protein
The P1 pellet was resuspended with two volumes of deionized water per unit wet weight, and to this was added nine volumes of 40% (w/w) aqueous sodium bromide. This and all subsequent operations were carried out on ice or at 4-6.degree. C. After 30 minutes, the suspension was diluted with 36 volumes of chilled water and centrifuged at 25,000.times.g for 30 minutes to give a pellet and a supernatant.
The resulting pellet was resuspended in 1-2 volumes of water and layered on a 20-40% (w/w) sodium bromide gradient and centrifuged at 8,000.times.g for 100 minutes. The layer banding at approximately 32% (w/w) sodium bromide (the "inclusions", or INC) was recovered and dialyzed overnight against water using a dialysis membrane with a 6-8 kDa MW cut-off. Particulate material was recovered by centrifugation at 25,000.times.g, resuspended in water, and aliquoted and assayed for protein by the method of Lowry and by SDS-PAGE.
The resulting supernatant was concentrated 3- to 4-fold using Centricon-10 concentrators, then dialyzed overnight against water using a dialysis membrane with a 6-8 kDa MW cut-off. Particulate material was recovered by centrifugation at 25,000.times.g, resuspended in water, and aliquoted and assayed for protein by the method of Lowry and by SDS-PAGE. This fraction was denoted as P1.P2.
The peptides in the pellet suspension were separated using SDS-PAGE (Laemlli, U.K., supra) in 15% acrylamide gels. The separated proteins were then electrophoretically blotted to a PVDF membrane (Millipore Corp.) in 10 mM CAPS pH 11.0, 10% MeOH at 100 V constant. After one hour the PVDF membrane was rinsed in water briefly and placed for 3 minutes in 0.25% Coomassie blue R-250, 50% methanol, 5% acetic acid. The stained membrane was destained in 40% MeOH, 5% acetic acid. The destained membrane was air-dried at room temperature (LeGendre et al., supra). The membrane was sequenced using automated gas phase Edman degradation (Hunkapillar et al., supra).
Protein analysis indicated the presence of two major polypeptides, with molecular weights of 47 kDa and 14 kDa. Molecular weights were measured against standard polypeptides of known molecular weight. This process provides only an estimate of true molecular weight. The 47 kDa band from PS149B1 migrated on SDS-PAGE in a manner indistinguishable from the 47 kDa protein from PS80JJ1. Likewise, the 14 kDa band from PS149B1 migrated on SDS-PAGE in a manner indistinguishable from 14 kDa bands from PS167H2 and PS80JJ1. Apart from these two polypeptides, which were estimated to account for 25-35% (47 kDa) and 35-55% (15 kDa) of the Coomassie staining material respectively, there may be minor bands, including those of estimated MW at 46 kDa, 130 kDa, and 70 kDa.
Protein analysis indicated that fraction INC contained a single polypeptide with MW of 47 kDa, and that fraction P1.P2 contained a single polypeptide with MW of 14 kDa. These polypeptides were recovered in yields greater than 50% from P1.
The N-terminal amino acid sequence for the purified 47 kDa protein from PS149B1 is: Met-Leu-Asp-Thr-Asn-Lys-Val-Tyr-Glu-Ile-Ser-Asn-His-Ala-Asn-Gly-Leu-Tyr-Ala-Ala-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO. 4).
The N-terminal amino acid sequence for the purified 14 kDa protein from PS149B1 is: Ser-Ala-Arg-Glu-Val-His-Ile-Asp-Val-Asn-Asn-Lys-Thr-Gly-His-Thr-Leu-Gln-Leu-Glu-Asp-Lys-Thr-Lys-Leu-Asp-Gly-Gly-Arg-Trp-Arg-Thr-Ser-Pro-Xaa-Asn-Val-Ala-Asn-Asp-Gln-Ile-Lys-Thr-Phe-Val-Ala-Glu-Ser-Asn (SEQ ID NO.5).
EXAMPLE 5
Amino Acid Sequence for 45 kDa and 14 kDa Toxins of PS167H2
The N-terminal amino acid sequence for the purified 45 kDa protein from PS167H2 is: Met-Leu-Asp-Thr-Asn-Lys-Ile-Tyr-Glu-Ile-Ser-Asn-Tyr-Ala-Asn-Gly-Leu-His-Ala-Ala-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO. 6).
The N-terminal amino acid sequence for the purified 14 kDa protein from PS167H2 is: Ser-Ala-Arg-Glu-Val-His-Ile-Asp-Val-Asn-Asn-Lys-Thr-Gly-His-Thr-Leu-Gln-Leu-Glu-Asp-Lys-Thr-Lys-Leu (SEQ ID NO. 7).
These amino acid sequences can be compared to the sequence obtained for the 47 kDa peptide obtained from 80JJ1 spore/crystal powders with the N-terminal sequence (SEQ ID NO. 1) and to the sequence obtained for the 14 kDa peptide obtained from 80JJ1 spore/crystal powders with the N-terminal sequence (SEQ ID NO. 3).
Clearly, the 45-47 kDa proteins are highly related and probably represent one gene family, and the 14 kDa proteins are highly related and probably represent another gene family.
EXAMPLE 6
Molecular Cloning, Expression, and DNA Sequence Analysis of a Novel .delta.-Endotoxin Gene from Bacillus thuringiensis Strain PS80JJ1
Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells grown to an optical density, at 600 nm, of 1.0. Cells were pelleted by centrifugation and resuspended in protoplast buffer (20 mg/ml lysozyme in 0.3 M sucrose, 25 mM Tris-Cl [pH 8.0], 25 mM EDTA). After incubation at 37.degree. C. for 1 hour, protoplasts were lysed by two cycles of freezing and thawing. Nine volumes of a solution of 0.1 M NaCl, 0.1% SDS, 0.1 M Tris-Cl were added to complete lysis. The cleared lysate was extracted twice with phenol:chloroform (1:1). Nucleic acids were precipitated with two volumes of ethanol and pelleted by centrifugation. The pellet was resuspended in TE buffer and RNase was added to a final concentration of 50 .mu.g/ml. After incubation at 37.degree. C. for 1 hour, the solution was extracted once each with phenol:chloroform (1:1) and TE-saturated chloroform. DNA was precipitated from the aqueous phase by the addition of one-tenth volume of 3 M NaOAc and two volumes of ethanol. DNA was pelleted by centrifugation, washed with 70% ethanol, dried, and resuspended in TE buffer.
An oligonucleotide probe for the gene encoding the PS80JJ1 45 kDa toxin was designed from N-terminal peptide sequence data. The sequence of the 29-base oligonucleotide probe was:
5'-ATG YTW GAT ACW AAT AAA GTW TAT GAA AT-3' (SEQ ID NO. 8)
This oligonucleotide was mixed at four positions as shown. This probe was radiolabeled with .sup.32 P and used in standard condition hybridization of Southern blots of PS80JJ1 total cellular DNA digested with various restriction endonucleases. Representative autoradiographic data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the 44.3 kDa toxin oligonucleotide probe of SEQ ID NO. 8 are presented in Table 3.
TABLE 3______________________________________RFLP of PS80JJ1 cellular DNA fragments on Southern blots that hybridized under standard conditions with the 44.3 kDa toxin gene oligonucleotide probe (SEQ ID NO. 8) Restriction Enzyme Approximate Fragment Size (kbp)______________________________________EcoRI 6.0 HindIII 8.3 KpnI 7.4 PstI 11.5 XbaI 9.1______________________________________
These DNA fragments identified in these analyses contain all or a segment of the PS80JJ1 45 kDa toxin gene. The approximate sizes of the hybridizing DNA fragments in Table 3 are in reasonable agreement with the sizes of a subset of the PS80JJ1 fragments hybridizing with a PS80JJ1 45 kDa toxin subgene probe used in separate experiments, as predicted (see Table 4, below).
A gene library was constructed from PS80JJ1 DNA partially digested with Sau3AI. Partial restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 9.3 to 23 kbp in size were excised from the gel, electroeluted from the gel slice, purified on an Elutip-D ion exchange column (Schleicher and Schuell, Keene, N.H.), and recovered by ethanol precipitation. The Sau3AI inserts were ligated into BamHI-digested LambdaGem-11 (Promega, Madison, Wis.). Recombinant phage were packaged and plated on E. coli KW251 cells. Plaques were screened by hybridization wit the oligonucleotide probe described above. Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).
Southern blot analysis revealed that one of the recombinant phage isolates contained an approximately 4.8 kbp XbaI-SacI band that hybridized to the PS80JJ1 toxin gene probe. The SacI site flanking the PS80JJ1 toxin gene is a phage vector cloning site, while the flanking XbaI site is located within the PS80JJ1 DNA insert. This DNA restriction fragment was subcloned by standard methods into pBluescript S/K (Stragagene, San Diego, Calif.) for sequence analysis. The resultant plasmid was designated pMYC2421. The DNA insert was also subcloned into pHTBlueII (an E. coli/B. thuringiensis shuttle vector comprised of pBluescript S/K [Stratagene, La Jolla, Calif.] and the replication origin from a resident B.t. plasmid [D. Lereclus et al. (1989) FEMS Microbiology Letters 60:211-218]) to yield pMYC2420.
An oligonucleotide probe for the gene encoding the PS80JJ1 14 kDa toxin was designed from N-terminal peptide sequence data. The sequence of the 28-base oligonucleotide probe was: 5'GW GAA GTW CAT ATW GAA ATW AAT AAT AC 3' (SEQ ID NO. 29). This oligonucleotide was mixed at four positions as shown. The probe was radiolabelled with .sup.32 P and used in standard condition hybridizations of Southern blots of PS80JJ1 total cellular and pMYC2421 DNA digested with various restriction endonucleases. These RFLP mapping experiments demonstrated that the gene encoding the 14 kDa toxin is located on the same genomic EcoRI fragment that contains the N-terminal coding sequence for the 44.3 kDa toxin.
To test expression of the PS80JJ1 toxin genes in B.t., pMYC2420 was transformed into the acrystalliferous (Cry-) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. Expression of both the approximately 14 and 44.3 kDa PS80JJ1 toxins encoded by pMYC2420 was demonstrated by SDS-PAGE analysis. Toxin crystal preparations from the recombinant CryB[pMYC2420] strain, MR536, were assayed and found to be active against western corn rootworm.
The PS80JJ1 toxin genes encoded by pMYC2421 were sequenced using the ABI373 automated sequencing system and associate software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO. 30. The termination codon of the 14 kDa toxin gene is 121 base pairs upstream (5') from the initiation codon of the 44.3 kDa toxin gene (FIG. 2). The PS80JJ1 14 kDa toxin open reading frame nucleotide sequence (SEQ ID NO. 31), the 44.3 kDa toxin open reading frame nucleotide sequence (SEQ ID NO. 10), and the respective deduced amino acid sequences (SEQ ID NO. 32 and SEQ ID NO. 11) are novel compared to other toxin genes encoding pesticidal proteins.
Thus, the nucleotide sequence encoding the 14 kDa toxin of PS80JJ1 is shown in SEQ ID NO. 31. The deduced amino acid sequence of the 14 kDa toxin of PS80JJ1 is shown in SEQ ID NO. 32. The nucleotide sequences encoding both the 14 and 45 kDa toxins of PS80JJ1, as well as the flanking sequences, are shown in SEQ ID NO. 30. The relationship of these sequences is shown in FIG. 2.
A subculture of E. coli NM522 containing plasmid pMYC2421 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Mar. 28, 1996. The accession number is NRRL B-21555.
EXAMPLE 7
RFLP and PCR Analysis of Additional Novel .delta.-Endotoxin Genes from Bacillus thuringiensis Strains PS149B1 and PS167H2
Two additional strains active against corn rootworm, PS149B1 and PS167H2, also produce parasporal protein crystals comprised in part of polypeptides approximately 14 and 45 kDa in size. Southern hybridization and partial DNA sequence analysis were used to examine the relatedness of these toxins to the PS80JJ1 toxins. DNA was extracted from these B.t. strains as described above, and standard Southern hybridizations were performed using the 14 kDa toxin oligonucleotide probe (SEQ ID NO. 29) and an approximately 800 bp PCR fragment of the PS80JJ1 44.3 kDa toxin gene-encoding sequence. Representative RFLP data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the 44.3 kDa toxin are presented in Table 4. Representative RFLP data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the approximately 14 kDa toxin are presented in Table
TABLE 4______________________________________RFLP of PS80JJ1, PS149B1, and PS167H2 cellular DNA fragments on Southern blots that hybridized with the approximately 800 bp PS80JJ1 44.3 kDa toxin subgene probe under standard conditions StrainRestriction PS80JJ1 PS149B1 PS167H2enzyme Approximate fragment size (kbp)______________________________________EcoRI 6.4 5.7 2.6 1.3 2.8 0.6 HindIII 8.2 6.2 4.4 KpnI 7.8 10.0 11.5 PstI 12.0 9.2 9.2 8.2 XbaI 9.4 10.9 10.9 SacI 17.5 15.5 11.1 13.1 10.5 6.3______________________________________
Each of the three strains exhibited unique RFLP patterns. The hybridizing DNA fragments from PS149B1 or PS167 H2 contain all or part of toxin genes with sequence homology to the PS80JJ1 44.3 kDa toxin.
TABLE 5______________________________________Restriction fragment length polymorphisms of PS80JJ1, PS149B1, and PS167H2 cellular DNA fragments on Southern blots that hybridized with the PS80JJ1 14 kDa toxin oligonucleotide probe under standard conditions Strain PS80JJ1 PS149B1 PS167H2Restriction enzyme Approximate fragment size (kbp)______________________________________EcoRI 5.6 2.7 2.7 HindIII 7.1 6.0 4.7 XbaI 8.4 11.2 11.2______________________________________
Each of the three strains exhibited unique RFLP patterns. The hybridizing DNA fragments from PS149B1 or PS167H2 contain all or part of toxin genes with sequence homology to the PS80JJ1 14 kDa toxin gene.
Portions of the toxin genes in PS149B1 or PS167H2 were amplified by PCR using forward and reverse oligonucleotide primer pairs designed based on the PS80JJ1 44.3 kDa toxin gene sequence. For PS149B1, the following primer pair was used:
Forward: 5'-ATG YTW GAT ACW AAT AAA GTW TAT GAA AT-3' (SEQ ID NO. 8) Reverse: 5'-GGA TTA TCT ATC TCT GAG TGT TCT TG-3' (SEQ ID NO. 9)
For PS167H2, the same primer pair was used. These PCR-derived fragments were sequenced using the ABI373 automated sequencing system and associated software. The partial gene and peptide sequences obtained are shown in SEQ ID NO. 12-15. These sequences contain portions of the nucleotide coding sequences and peptide sequences for novel corn rootworm-active toxins present in B.t. strains PS149B1 or PS167H2.
EXAMPLE 8
Molecular Cloning and DNA Sequence Analysis of Novel .delta.-Endotoxin Genes from Bacillus thuringiensis Strains PS149B1 and PS167H2
Total cellular DNA was extracted from strains PS149B1 and PS167H2 as described for PS80JJ1. Gene libraries of size-fractionated Sau3A partial restriction fragments were constructed in Lambda-Gem11 for each respective strain as previously described. Recombinant phage were packaged and plated on E. coli KW251 cells. Plaques were screened by hybridization with the oligonucleotide probe specific for the 44 kDa toxin gene. Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).
For PS167H2, Southern blot analysis revealed that one of the recombinant phage isolates contained an approximately 4.0 to 4.4 kbp HindIII band that hybridized to the PS80JJ1 44 kDa toxin gene 5' oligonucleotide probe (SEQ ID NO. 8). This DNA restriction fragment was subcloned by standard methods into pBluescript S/K (Stratgene, San Diego, Calif.) for sequence analysis. The fragment was also subcloned into the high copy number shuttle vector, pHT370 (Arantes, O., D. Lereclus [1991] Gene 108:115-119) for expression analyses in Bacillus thuringiensis (see below). The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2427.
The PS167H2 toxin genes encoded by pMYC2427 were sequenced using the ABI automated sequencing system and associated software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO. 34. The termination codon of the 14 kDa toxin gene is 107 base pairs upstream (5') from the initiation codon of the 44 kDa toxin gene. The PS167H2 14 kDa toxin coding sequence (SEQ ID NO. 35), the 44 kDa toxin coding sequence (SEQ ID NO. 37), and the respective deduced amino acid sequences, SEQ ID NO. 36 and SEQ ID NO. 38, are novel compared to other known toxin genes encoding pesticidal proteins. The toxin genes are arranged in a similar manner to, and have some homology with, the PS80JJ1 14 and 44 kDa toxins.
A subculture of E. coli NM522 containing plasmid pMYC2427 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Mar. 26, 1997. The accession number is NRRL B-21672.
For PS149B1, Southern blot analysis using the PS80JJ1 44 kDa oligonucleotide 5' probe (SEQ ID NO. 8) demonstrated hybridization of an approximately 5.9 kbp ClaI DNA fragment. Complete ClaI digests of PS149B1 genomic DNA were size fractionated on agarose gels and cloned into pHTBlueII. The fragment was also subcloned into the high copy number shuttle vector, pHT370 (Arantes, O., D. Lerclus [1991] Gene 108:115-119) for expression analyses in Bacillus thuringiensis (see below). The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2429.
The PS149B1 toxin genes encoded by pMYC2429 were sequenced using the ABI automated sequencing system and associated software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO. 39. The termination codon of the 14 kDa toxin gene is 108 base pairs upstream (5') from the initiation codon of the 44 kDa toxin gene. The PS149B1 14 kDa toxin coding sequence (SEQ ID NO. 40), the 44 kDa toxin coding sequence (SEQ ID NO. 42), and the respective deduced amino acid sequences, SEQ ID NO. 41 and SEQ ID NO. 43, are novel compared to other known toxin genes encoding pesticidal proteins. The toxin genes are arranged in a similar manner as, and have some homology with, the PS80JJ1 and PS167H2 14 and 44 kDa toxins. Together, these three toxin operons comprise a new family of pesticidal toxins.
A subculture of E. coli NM522 containing plasmid pMYC2429 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Mar. 26, 1997. The accession number is NRRL B-21673.
EXAMPLE 9
PCR Amplification for Identification and Cloning Novel Corn Rootworm-Active Toxin
The DNA and peptide sequences of the three novel approximately 45 kDa corn rootworm-active toxins from PS80JJ1, PS149B1, and PS167H2 (SEQ ID NOS. 12-15) were aligned with the Genetics Computer group sequence analysis program Pileup using a gap weight of 3.00 and a gap length weight of 0.10. The sequence alignments were used to identify conserved peptide sequences to which oligonucleotide primers were designed that were likely to hybridize to genes encoding members of this novel toxin family. Such primers can be used in PCR to amplify diagnostic DNA fragments for these and related toxin genes. Numerous primer designs to various sequences are possible, four of which are described here to provide an example. These peptide sequences are:
Asp-Ile-Asp-Asp-Tyr-Asn-Leu (SEQ ID NO. 16) - Trp-Phe-Leu-Phe-Pro-Ile-Asp (SEQ ID NO. 17) - Gln-Ile-Lys-Thr-Thr-Pro-Tyr-Tyr (SEQ ID NO. 18) - Tyr-Glu-Trp-Gly-Thr-Glu. (SEQ ID NO. 19)
The corresponding nucleotide sequences are:
5'-GATATWGATGAYTAYAAYTTR-3' (SEQ ID NO. 20) - 5'-TGGTTTTTRTTTCCWATWGAY-3' (SEQ ID NO. 21) - 5'-CAAATHAAAACWACWCCATATTAT-3' (SEQ ID NO. 22) - 5'-TAYGARTGGGGHACAGAA-3'. (SEQ ID NO. 23)
Forward primers for polymerase amplification in thermocycle reactions were designed based on the nucleotide sequences of SEQ ID NOS. 20 and 21.
Reverse primers were designed based on the reverse complement of SEQ ID NOS. 22 and
5'-ATAATATGGWGTWGTTTTDATTTG-3' (SEQ ID NO. 24) 5'-TTCTGTDCCCCAYTCRTA-3'. (SEQ ID NO. 25)
These primers can be used in combination to amplify DNA fragments of the following sizes (Table 6) that identify genes encoding novel corn rootworm toxins.
TABLE 6______________________________________Predicted sizes of diagnostic DNA fragments (base pairs) amplifiable with primers specific for novel corn rootworm-active toxins Primer pair (SEQ ID NO.) DNA fragment size (bp)______________________________________20 + 24 495 20 + 25 594 21 + 24 471 21 + 25 580______________________________________
Similarly, entire genes encoding novel corn rootworm-active toxins can be isolated by polymerase amplification in thermocycle reactions using primers designed based on DNA sequences flanking the open reading frames. For the PS80JJ1 44.3 kDa toxin, one such primer pair was designed, synthesized, and used to amplify a diagnostic 1613 bp DNA fragment that included the entire toxin coding sequence. These primers are:
Forward: 5'-CTCAAAGCGGATCAGGAG-3' (SEQ ID NO. 26) Reverse: 5'-GCGTATTCGGATATGCTTGG-3'. (SEQ ID NO. 27)
For PCR amplification of the PS80JJ1 14 kDa toxin, the oligonucleotide coding for the N-terminal peptide sequence (SEQ ID NO. 29) can be used in combination with various reverse oligonucleotide primers based on the sequences in the PS80JJ1 toxin gene locus. One such reverse primer has the following sequence:
5' CATGAGATTTATCTCCTGATCCGC 3' (SEQ ID NO. 33).
When used in standard PCR reactions, this primer pair amplified a diagnostic 1390 bp DNA fragment that includes the entire 14 kDa toxin coding sequence and some 3' flanking sequences corresponding to the 121 base intergenic spacer and a portion of the 44.3 kDa toxin gene. When used in combination with the 14 kDa forward primer, PCR will generate a diagnostic 322 base pair DNA fragment.
EXAMPLE 10
Bioassay of Protein
A preparation of the insoluble fraction from the dialyzed NaBr extract of PS80JJ1 containing the 47 kDa, 45 kDa, and 15 kDa peptides was bioassayed against Western corn rootworm and found to exhibit significant toxin activity.
EXAMPLE 11
Bioassay of Protein
The purified protein fractions from PS149B1 were bioassayed against western corn rootworm and found to exhibit significant toxin activity when combined. In fact, the combination restored activity to that noted in the original preparation (P1). The following bioassay data set presents percent mortality and demonstrates this effect.
TABLE 7______________________________________Concentration (.mu.g/cm.sup.2) P1 INC P1.P2 INC + P1.P2______________________________________300 88, 100, 94 19 13 100 100 94, 50, 63 31 38 94 33.3 19, 19, 44 38 13 50 11.1 13, 56, 25 12 31 13 3.7 0, 50, 0 0 31 13 1.2 13, 43, 12 0 12 19 0.4 6, 12, 6 25 19 6______________________________________
EXAMPLE 12
Clone Dose-Response Bioassays
The PS80JJ1 toxin operon was also subcloned from pMYC2421 into pHT370 for direct comparison of bioactivity with the recombinant toxins closed from PS149B1 and PS167H2. The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2426.
A subculture of E. coli NM522 containing plasmid pMYC2426 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Mar. 26, 1997. The accession number is NRRL B-21671.
To test expression of the PS80JJ1, PS149B1 and PS167H2 toxin genes in B.t., pMYC2426, pMYC2427 and pMYC2429 were separately transformed into the acrystalliferous(Cry-) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. The recombinant strains were designated MR543 (CryB [pMYC2426]), MR544 (CryB [pMYC2427]) and MR546 (CryB [pMYC2429]), respectively. Expression of both the approximately 14 and 44 kDa toxins was demonstrated by SDS-PAGE analysis for each recombinant strain.
Toxin crystal preparations from the recombinant strains were assayed against western corn rootworm. Their diet was amended with sorbic acid and SIGMA pen-strep-ampho-B. The material was top-loaded at a rate of 50 .mu.l of suspension per cm.sup.2 diet surface area. Bioassays were run with neonate Western corn rootworm larvae for 4 days at approximately 25.degree. C. Percentage mortality and top-load LC.sub.50 estimates for the clones (pellets) are set forth in Table
TABLE 8______________________________________ Percentage mortality at given protein concentration (.mu.g/cm.sup.2)Sample 50 5 0.5______________________________________MR543 pellet 44 19 9 MR544 pellet 72 32 21 MR546 pellet 52 32 21 dH2O 7______________________________________
EXAMPLE 13
Insertion and Expression of Toxin Genes Into Plants
One aspect of the subject invention is the transformation of plants with genes encoding the insecticidal toxin. The transformed plants are resistant to attack by the target pest.
The novel corn rootworm-active genes described here can be optimized for expression in other organisms. Maize optimized gene sequences encoding the 14 and 44 kDa PS80JJ1 toxins are disclosed in SEQ ID NO. 44 and SEQ ID NO. 45, respectively.
Genes encoding pesticidal toxins, as disclosed herein, can be inserted into plant cells using a variety of techniques which are well known in the art. For example, a large number of cloning vectors comprising a replication system in E. coli and a marker that permits selection of the transformed cells are available for preparation for the insertion of foreign genes into higher plants. The vectors comprise, for example, pBR322, pUC series, M13mp series, pACYC184, et. Accordingly, the sequence encoding the B.t. toxin can be inserted into the vector at a suitable restriction site. The resulting plasmid is used for transformation into E. coli. The E. coli cells are cultivated in a suitable nutrient medium, then harvested and lysed. The plasmid is recovered. Sequence analysis, restriction analysis, electrophoresis, and other biochemical-molecularbiological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each plasmid sequence can be cloned in the same or other plasmids. Depending on the method of inserting desired genes into the plant, other DNA sequences may be necessary. If, for example, the Ti or Ri plasmid is used for the transformation of the plant cell, then at least the right border, but often the right and the left border of the Ti or Ri plasmid T-DNA, has to be joined as the flanking region of the genes to be inserted.
The use of T-DNA for the transformation of plant cells has been intensively researched and sufficiently described in EP 120 516; Hoekema (1985) In: The Binary Plant Vector System, Offset-durkkerij Kanters B. V., Alblasserdam, Chapter 5; Fraley et al., Crit. Rev. Plant Sci. 4:1-46; and An et al. (1985) EMBO J. 4:277-287.
Once the inserted DNA has been integrated in the genome, it is relatively stable there and, as a rule, does not come out again. It normally contains a section marker that confers on the transformed plant cells resistance to a biocide or an antibiotic, such as kanamycin, G 418, bleomycin, hygromycin, or chloramphenicol, inter alia. The individually employed marker should accordingly permit the selection of transformed cells rather than cells that do not contain the inserted DNA.
A large number of techniques are available for inserting DNA into a plant host cell. Those techniques include transformation with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agent, fusion, injection biolistics (miocroparticle bombardment), or electroporation as well as other possible methods. If Agrobacteria are used for the transformation, the DNA to be inserted has to be cloned into special plasmids, namely either into an intermediate vector or into a binary vector. The intermediate vectors can be integrated into the Ti or Ri plasmid by homologous recombination owing to sequences that are homologous to sequences in the T-DNA. The Ti or Ri plasmid also comprises the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate themselves in Agrobacteria. The intermediate vector can be transferred into Agrobacterium tumefaciens by means of a helper plasmid (conjugation). Binary vectors can replicate themselves both in E. coli and in Agrobacteria. They comprise a selection marker gene and a linker or polylinker which are framed by the right and left T-DNA border regions. They can be transformed directly into Agrobacteria (Holsters et al. [1978] Mol. Gen. Genet. 163:181-187). The Agrobacterium used as host cell is to comprise a plasmid carrying a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be contained. The bacterium so transformed is used for the transformation of plant cells. Plant explants can advantageously be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes for the transfer of the DNA into the plant cell. Whole plants can then be regenerated from the infected plant material (for example, pieces of leaf, segments of stalk, roots, but also protoplasts or suspension-cultivated cells) in a suitable medium, which may contain antibiotics or biocides for selection. The plants so obtained can then be tested for the presence of the inserted DNA. No special demands are made of the plasmids in the case of injection and electroporation. It is possible to use ordinary plasmids, such as, for example, pUC derivatives.
The transformed cells grow inside the plants in the usual manner. They can form germ cells and transmit the transformed trait(s) to progeny plants. Such plants can be grown in the manner and crossed with plants that have the same transformed hereditary factors or other hereditary factors. The resulting hybrid individuals have the corresponding phenotypic properties.
In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage has been optimized for plants. See, for example, U.S. Pat. No. 5,380,831, which is hereby incorporated by reference. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxin. Methods for creating synthetic B.t. genes for use in plants are known in the art.
EXAMPLE 14
Cloning of B.t. Genes Into Insect Viruses
A number of viruses are known to infect insects. These viruses include, for example, baculoviruses and entomopoxviruses. In one embodiment of the subject invention, genes encoding the insecticidal toxins, as described herein, can be placed within the genome of the insect virus, thus enhancing the pathogenicity of the virus. Methods for constructing insect viruses which comprise B.t. toxin genes are well known and readily practiced by those skilled in the art. These procedures are described, for example, in Merryweather et al. (Merryweather, A. T., U. Weyer, M. P. G. Harris, M. Hirst, T. Booth, R. D. Possee (1990) J. Gen Virol. 71:1535-1544) and Martens et al. (Martens, J. W. M., G. Honee, D. Zuidema, J. W. M. van Lent, B. Visser, J. M. Vlak (1990) Appl. Environmental Microbiol. 56(9):2764-2770).
It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims.
__________________________________________________________________________# SEQUENCE LISTING - - - - (1) GENERAL INFORMATION: - - (iii) NUMBER OF SEQUENCES: 45 - - - - (2) INFORMATION FOR SEQ ID NO:1: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: peptide - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1: - - Met Leu Asp Thr Asn 1 5 - - - - (2) INFORMATION FOR SEQ ID NO:2: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: - - Met Leu Asp Thr Asn Lys Val Tyr Glu Ile Se - #r Asn Leu Ala AsnGly 1 5 - # 10 - # 15 - - Leu Tyr Thr Ser Thr Tyr Leu Ser Leu 20 - # 25 - - - - (2) INFORMATION FOR SEQ ID NO:3: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: - - Ser Ala Arg Glu Val His Ile Glu Ile Asn As - #n Thr Arg His Thr Leu 1 5 - # 10 - # 15 - - Gln Leu Glu Ala Lys Thr Lys Leu 20 - - - - (2) INFORMATION FOR SEQ ID NO:4: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: - - Met Leu Asp Thr Asn Lys Val Tyr Glu Ile Se - #r Asn His Ala Asn Gly 1 5 - # 10 - # 15 - - Leu Tyr Ala Ala Thr Tyr Leu Ser Leu 20 - # 25 - - - - (2) INFORMATION FOR SEQ ID NO:5: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 50 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: - - Ser Ala Arg Glu Val His Ile Asp Val Asn As - #n Lys Thr Gly His Thr 1 5 - # 10 - # 15 - - Leu Gln Leu Glu Asp Lys Thr Lys Leu Asp Gl - #y Gly Arg Trp Arg Thr 20 - # 25 - # 30 - - Ser Pro Xaa Asn Val Ala Asn Asp Gln Ile Ly - #s Thr Phe Val Ala Glu 35 - # 40 - # 45 - - Ser Asn 50 - - - - (2) INFORMATION FOR SEQ ID NO:6: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: - - Met Leu Asp Thr Asn Lys Ile Tyr Glu Ile Se - #r Asn Tyr Ala Asn Gly 1 5 - # 10 - # 15 - - Leu His Ala Ala Thr Tyr Leu Ser Leu 20 - # 25 - - - - (2) INFORMATION FOR SEQ ID NO:7: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: - - Ser Ala Arg Glu Val His Ile Asp Val Asn As - #n Lys Thr Gly His Thr 1 5 - # 10 - # 15 - - Leu Gln Leu Glu Asp Lys Thr Lys Leu 20 - # 25 - - - - (2) INFORMATION FOR SEQ ID NO:8: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: - - ATGNTNGATA CNAATAAAGT NTATGAAAT - # - # 29 - - - - (2) INFORMATION FOR SEQ ID NO:9: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: - - GGATTATCTA TCTCTGAGTG TTCTTG - # - # 26 - - - - (2) INFORMATION FOR SEQ ID NO:10: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1158 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: - - ATGTTAGATA CTAATAAAGT TTATGAAATA AGCAATCTTG CTAATGGATT AT -#ATACATCA 60 - - ACTTATTTAA GTCTTGATGA TTCAGGTGTT AGTTTAATGA GTAAAAAGGA TG -#AAGATATT 120 - - GATGATTACA ATTTAAAATG GTTTTTATTT CCTATTGATA ATAATCAATA TA -#TTATTACA 180 - - AGCTATGGAG CTAATAATTG TAAAGTTTGG AATGTTAAAA ATGATAAAAT AA -#ATGTTTCA 240 - - ACTTATTCTT CAACAAACTC TGTACAAAAA TGGCAAATAA AAGCTAAAGA TT -#CTTCATAT 300 - - ATAATACAAA GTGATAATGG AAAGGTCTTA ACAGCAGGAG TAGGTCAATC TC -#TTGGAATA 360 - - GTACGCCTAA CTGATGAATT TCCAGAGAAT TCTAACCAAC AATGGAATTT AA -#CTCCTGTA 420 - - CAAACAATTC AACTCCCACA AAAACCTAAA ATAGATGAAA AATTAAAAGA TC -#ATCCTGAA 480 - - TATTCAGAAA CCGGAAATAT AAATCCTAAA ACAACTCCTC AATTAATGGG AT -#GGACATTA 540 - - GTACCTTGTA TTATGGTAAA TGATTCAAAA ATAGATAAAA ACACTCAAAT TA -#AAACTACT 600 - - CCATATTATA TTTTTAAAAA ATATAAATAC TGGAATCTAG CAAAAGGAAG TA -#ATGTATCT 660 - - TTACTTCCAC ATCAAAAAAG ATCATATGAT TATGAATGGG GTACAGAAAA AA -#ATCAAAAA 720 - - ACAACTATTA TTAATACAGT AGGATTGCAA ATTAATATAG ATTCAGGAAT GA -#AATTTGAA 780 - - GTACCAGAAG TAGGAGGAGG TACAGAAGAC ATAAAAACAC AATTAACTGA AG -#AATTAAAA 840 - - GTTGAATATA GCACTGAAAC CAAAATAATG ACGAAATATC AAGAACACTC AG -#AGATAGAT 900 - - AATCCAACTA ATCAACCAAT GAATTCTATA GGACTTCTTA TTTATACTTC TT -#TAGAATTA 960 - - TATCGATATA ACGGTACAGA AATTAAGATA ATGGACATAG AAACTTCAGA TC -#ATGATACT 1020 - - TACACTCTTA CTTCTTATCC AAATCATAAA GAAGCATTAT TACTTCTCAC AA -#ACCATTCG 1080 - - TATGAAGAAG TAGAAGAAAT AACAAAAATA CCTAAGCATA CACTTATAAA AT -#TGAAAAAA 1140 - - CATTATTTTA AAAAATAA - # - # - #1158 - - - - (2) INFORMATION FOR SEQ ID NO:11: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 385 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: - - Met Leu Asp Thr Asn Lys Val Tyr Glu Ile Se - #r Asn Leu Ala Asn Gly 1 5 - # 10 - # 15 - - Leu Tyr Thr Ser Thr Tyr Leu Ser Leu Asp As - #p Ser Gly Val Ser Leu 20 - # 25 - # 30 - - Met Ser Lys Lys Asp Glu Asp Ile Asp Asp Ty - #r Asn Leu Lys Trp Phe 35 - # 40 - # 45 - - Leu Phe Pro Ile Asp Asn Asn Gln Tyr Ile Il - #e Thr Ser Tyr Gly Ala 50 - # 55 - # 60 - - Asn Asn Cys Lys Val Trp Asn Val Lys Asn As - #p Lys Ile Asn Val Ser 65 - #70 - #75 - #80 - - Thr Tyr Ser Ser Thr Asn Ser Val Gln Lys Tr - #p Gln Ile Lys Ala Lys 85 - # 90 - # 95 - - Asp Ser Ser Tyr Ile Ile Gln Ser Asp Asn Gl - #y Lys Val Leu Thr Ala 100 - # 105 - # 110 - - Gly Val Gly Gln Ser Leu Gly Ile Val Arg Le - #u Thr Asp Glu Phe Pro 115 - # 120 - # 125 - - Glu Asn Ser Asn Gln Gln Trp Asn Leu Thr Pr - #o Val Gln Thr Ile Gln 130 - # 135 - # 140 - - Leu Pro Gln Lys Pro Lys Ile Asp Glu Lys Le - #u Lys Asp His Pro Glu 145 1 - #50 1 - #55 1 -#60 - - Tyr Ser Glu Thr Gly Asn Ile Asn Pro Lys Th - #r Thr Pro Gln LeuMet 165 - # 170 - # 175 - - Gly Trp Thr Leu Val Pro Cys Ile Met Val As - #n Asp Ser Lys Ile Asp 180 - # 185 - # 190 - - Lys Asn Thr Gln Ile Lys Thr Thr Pro Tyr Ty - #r Ile Phe Lys Lys Tyr 195 - # 200 - # 205 - - Lys Tyr Trp Asn Leu Ala Lys Gly Ser Asn Va - #l Ser Leu Leu Pro His 210 - # 215 - # 220 - - Gln Lys Arg Ser Tyr Asp Tyr Glu Trp Gly Th - #r Glu Lys Asn Gln Lys 225 2 - #30 2 - #35 2 -#40 - - Thr Thr Ile Ile Asn Thr Val Gly Leu Gln Il - #e Asn Ile Asp SerGly 245 - # 250 - # 255 - - Met Lys Phe Glu Val Pro Glu Val Gly Gly Gl - #y Thr Glu Asp Ile Lys 260 - # 265 - # 270 - - Thr Gln Leu Thr Glu Glu Leu Lys Val Glu Ty - #r Ser Thr Glu Thr Lys 275 - # 280 - # 285 - - Ile Met Thr Lys Tyr Gln Glu His Ser Glu Il - #e Asp Asn Pro Thr Asn 290 - # 295 - # 300 - - Gln Pro Met Asn Ser Ile Gly Leu Leu Ile Ty - #r Thr Ser Leu Glu Leu 305 3 - #10 3 - #15 3 -#20 - - Tyr Arg Tyr Asn Gly Thr Glu Ile Lys Ile Me - #t Asp Ile Glu ThrSer 325 - # 330 - # 335 - - Asp His Asp Thr Tyr Thr Leu Thr Ser Tyr Pr - #o Asn His Lys Glu Ala 340 - # 345 - # 350 - - Leu Leu Leu Leu Thr Asn His Ser Tyr Glu Gl - #u Val Glu Glu Ile Thr 355 - # 360 - # 365 - - Lys Ile Pro Lys His Thr Leu Ile Lys Leu Ly - #s Lys His Tyr Phe Lys 370 - # 375 - # 380 - - Lys 385 - - - - (2) INFORMATION FOR SEQ ID NO:12: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 834 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: - - GGACTATATG CAGCAACTTA TTTAAGTTTA GATGATTCAG GTGTTAGTTT AA -#TGAATAAA 60 - - AATGATGATG ATATTGATGA TTATAACTTA AAATGGTTTT TATTTCCTAT TG -#ATGATGAT 120 - - CAATATATTA TTACAAGCTA TGCAGCAAAT AATTGTAAAG TTTGGAATGT TA -#ATAATGAT 180 - - AAAATAAATG TTTCGACTTA TTCTTCAACA AATTCAATAC AAAAATGGCA AA -#TAAAAGCT 240 - - AATGGTTCTT CATATGTAAT ACAAAGTGAT AATGGAAAAG TCTTAACAGC AG -#GAACCGGT 300 - - CAAGCTCTTG GATTGATACG TTTAACTGAT GAATCCTCAA ATAATCCCAA TC -#AACAATGG 360 - - AATTTAACTT CTGTACAAAC AATTCAACTT CCACAAAAAC CTATAATAGA TA -#CAAAATTA 420 - - AAAGATTATC CCAAATATTC ACCAACTGGA AATATAGATA ATGGAACATC TC -#CTCAATTA 480 - - ATGGGATGGA CATTAGTACC TTGTATTATG GTAAATGATC CAAATATAGA TA -#AAAATACT 540 - - CAAATTAAAA CTACTCCATA TTATATTTTA AAAAAATATC AATATTGGCA AC -#GAGCAGTA 600 - - GGAAGTAATG TAGCTTTACG TCCACATGAA AAAAAATCAT ATACTTATGA AT -#GGGGCACA 660 - - GAAATAGATC AAAAAACAAC AATTATAAAT ACATTAGGAT TTCAAATCAA TA -#TAGATTCA 720 - - GGAATGAAAT TTGATATACC AGAAGTAGGT GGAGGTACAG ATGAAATAAA AA -#CACAACTA 780 - - AATGAAGAAT TAAAAATAGA ATATAGTCAT GAAACTAAAA TAATGGAAAA AT - #AT 834 - - - - (2) INFORMATION FOR SEQ ID NO:13: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 278 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: - - Gly Leu Tyr Ala Ala Thr Tyr Leu Ser Leu As - #p Asp Ser Gly Val Ser 1 5 - # 10 - # 15 - - Leu Met Asn Lys Asn Asp Asp Asp Ile Asp As - #p Tyr Asn Leu Lys Trp 20 - # 25 - # 30 - - Phe Leu Phe Pro Ile Asp Asp Asp Gln Tyr Il - #e Ile Thr Ser Tyr Ala 35 - # 40 - # 45 - - Ala Asn Asn Cys Lys Val Trp Asn Val Asn As - #n Asp Lys Ile Asn Val 50 - # 55 - # 60 - - Ser Thr Tyr Ser Ser Thr Asn Ser Ile Gln Ly - #s Trp Gln Ile Lys Ala 65 - #70 - #75 - #80 - - Asn Gly Ser Ser Tyr Val Ile Gln Ser Asp As - #n Gly Lys Val Leu Thr 85 - # 90 - # 95 - - Ala Gly Thr Gly Gln Ala Leu Gly Leu Ile Ar - #g Leu Thr Asp Glu Ser 100 - # 105 - # 110 - - Ser Asn Asn Pro Asn Gln Gln Trp Asn Leu Th - #r Ser Val Gln Thr Ile 115 - # 120 - # 125 - - Gln Leu Pro Gln Lys Pro Ile Ile Asp Thr Ly - #s Leu Lys Asp Tyr Pro 130 - # 135 - # 140 - - Lys Tyr Ser Pro Thr Gly Asn Ile Asp Asn Gl - #y Thr Ser Pro Gln Leu 145 1 - #50 1 - #55 1 -#60 - - Met Gly Trp Thr Leu Val Pro Cys Ile Met Va - #l Asn Asp Pro AsnIle 165 - # 170 - # 175 - - Asp Lys Asn Thr Gln Ile Lys Thr Thr Pro Ty - #r Tyr Ile Leu Lys Lys 180 - # 185 - # 190 - - Tyr Gln Tyr Trp Gln Arg Ala Val Gly Ser As - #n Val Ala Leu Arg Pro 195 - # 200 - # 205 - - His Glu Lys Lys Ser Tyr Thr Tyr Glu Trp Gl - #y Thr Glu Ile Asp Gln 210 - # 215 - # 220 - - Lys Thr Thr Ile Ile Asn Thr Leu Gly Phe Gl - #n Ile Asn Ile Asp Ser 225 2 - #30 2 - #35 2 -#40 - - Gly Met Lys Phe Asp Ile Pro Glu Val Gly Gl - #y Gly Thr Asp GluIle 245 - # 250 - # 255 - - Lys Thr Gln Leu Asn Glu Glu Leu Lys Ile Gl - #u Tyr Ser His Glu Thr 260 - # 265 - # 270 - - Lys Ile Met Glu Lys Tyr 275 - - - - (2) INFORMATION FOR SEQ ID NO:14: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 829 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: - - ACATGCAGCA ACTTATTTAA GTTTAGATGA TTCAGGTGTT AGTTTAATGA AT -#AAAAATGA 60 - - TGATGATATT GATGACTATA ATTTAAGGTG GTTTTTATTT CCTATTGATG AT -#AATCAATA 120 - - TATTATTACA AGCTACGCAG CGAATAATTG TAAGGTTTGG AATGTTAATA AT -#GATAAAAT 180 - - AAATGTTTCA ACTTATTCTT CAACAAACTC GATACAGAAA TGGCAAATAA AA -#GCTAATGC 240 - - TTCTTCGTAT GTAATACAAA GTAATAATGG GAAAGTTCTA ACAGCAGGAA CC -#GGTCAATC 300 - - TCTTGGATTA ATACGTTTAA CGGATGAATC ACCAGATAAT CCCAATCAAC AA -#TGGAATTT 360 - - AACTCCTGTA CAAACAATTC AACTCCCACC AAAACCTACA ATAGATACAA AG -#TTAAAAGA 420 - - TTACCCCAAA TATTCACAAA CTGGCAATAT AGACAAGGGA ACACCTCCTC AA -#TTAATGGG 480 - - ATGGACATTA ATACCTTGTA TTATGGTAAA TGATCCCAAT ATAGATAAAA AC -#ACTCAAAT 540 - - CAAAACTACT CCATATTATA TTTTAAAAAA ATATCAATAT TGGCAACAAG CA -#GTAGGAAG 600 - - TAATGTAGCT TTACGTCCGC ATGAAAAAAA ATCATATGCT TATGAGTGGG GT -#ACAGAAAT 660 - - AGATCAAAAA ACAACTATCA TTAATACATT AGGATTTCAG ATTAATATAG AT -#TCGGGAAT 720 - - GAAATTTGAT ATACCAGAAG TAGGTGGAGG TACAGATGAA ATAAAAACAC AA -#TTAAACGA 780 - - AGAATTAAAA ATAGAATATA GCCGTGAAAC CAAAATAATG GAAAAATAT - # 829 - - - - (2) INFORMATION FOR SEQ ID NO:15: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 276 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: - - His Ala Ala Thr Tyr Leu Ser Leu Asp Asp Se - #r Gly Val Ser Leu Met 1 5 - # 10 - # 15 - - Asn Lys Asn Asp Asp Asp Ile Asp Asp Tyr As - #n Leu Arg Trp Phe Leu 20 - # 25 - # 30 - - Phe Pro Ile Asp Asp Asn Gln Tyr Ile Ile Th - #r Ser Tyr Ala Ala Asn 35 - # 40 - # 45 - - Asn Cys Lys Val Trp Asn Val Asn Asn Asp Ly - #s Ile Asn Val Ser Thr 50 - # 55 - # 60 - - Tyr Ser Ser Thr Asn Ser Ile Gln Lys Trp Gl - #n Ile Lys Ala Asn Ala 65 - #70 - #75 - #80 - - Ser Ser Tyr Val Ile Gln Ser Asn Asn Gly Ly - #s Val Leu Thr Ala Gly 85 - # 90 - # 95 - - Thr Gly Gln Ser Leu Gly Leu Ile Arg Leu Th - #r Asp Glu Ser Pro Asp 100 - # 105 - # 110 - - Asn Pro Asn Gln Gln Trp Asn Leu Thr Pro Va - #l Gln Thr Ile Gln Leu 115 - # 120 - # 125 - - Pro Pro Lys Pro Thr Ile Asp Thr Lys Leu Ly - #s Asp Tyr Pro Lys Tyr 130 - # 135 - # 140 - - Ser Gln Thr Gly Asn Ile Asp Lys Gly Thr Pr - #o Pro Gln Leu Met Gly 145 1 - #50 1 - #55 1 -#60 - - Trp Thr Leu Ile Pro Cys Ile Met Val Asn As - #p Pro Asn Ile AspLys 165 - # 170 - # 175 - - Asn Thr Gln Ile Lys Thr Thr Pro Tyr Tyr Il - #e Leu Lys Lys Tyr Gln 180 - # 185 - # 190 - - Tyr Trp Gln Gln Ala Val Gly Ser Asn Val Al - #a Leu Arg Pro His Glu 195 - # 200 - # 205 - - Lys Lys Ser Tyr Ala Tyr Glu Trp Gly Thr Gl - #u Ile Asp Gln Lys Thr 210 - # 215 - # 220 - - Thr Ile Ile Asn Thr Leu Gly Phe Gln Ile As - #n Ile Asp Ser Gly Met 225 2 - #30 2 - #35 2 -#40 - - Lys Phe Asp Ile Pro Glu Val Gly Gly Gly Th - #r Asp Glu Ile LysThr 245 - # 250 - # 255 - - Gln Leu Asn Glu Glu Leu Lys Ile Glu Tyr Se - #r Arg Glu Thr Lys Ile 260 - # 265 - # 270 - - Met Glu Lys Tyr 275 - - - - (2) INFORMATION FOR SEQ ID NO:16: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: peptide - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: - - Asp Ile Asp Asp Tyr Asn Leu 1 5 - - - - (2) INFORMATION FOR SEQ ID NO:17: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: peptide - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: - - Trp Phe Leu Phe Pro Ile Asp 1 5 - - - - (2) INFORMATION FOR SEQ ID NO:18: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: peptide - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: - - Gln Ile Lys Thr Thr Pro Tyr Tyr 1 5 - - - - (2) INFORMATION FOR SEQ ID NO:19: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: peptide - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: - - Tyr Glu Trp Gly Thr Glu 1 5 - - - - (2) INFORMATION FOR SEQ ID NO:20: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: - - GATATNGATG ANTAYAAYTT N - # - # - #21 - - - - (2) INFORMATION FOR SEQ ID NO:21: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: - - TGGTTTTTNT TTCCNATNGA N - # - # - #21 - - - - (2) INFORMATION FOR SEQ ID NO:22: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: - - CAAATNAAAA CNACNCCATA TTAT - # - # 24 - - - - (2) INFORMATION FOR SEQ ID NO:23: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: - - TANGANTGGG GNACAGAA - # - # - # 18 - - - - (2) INFORMATION FOR SEQ ID NO:24: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: - - ATAATATGGN GTNGTTTTNA TTTG - # - # 24 - - - - (2) INFORMATION FOR SEQ ID NO:25: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: - - TTCTGTNCCC CANTCNTA - # - # - # 18 - - - - (2) INFORMATION FOR SEQ ID NO:26: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: - - CTCAAAGCGG ATCAGGAG - # - # - # 18 - - - - (2) INFORMATION FOR SEQ ID NO:27: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: - - GCGTATTCGG ATATGCTTGG - # - # - # 20 - - - - (2) INFORMATION FOR SEQ ID NO:28: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 386 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 1 5 - # 10 - # 15 - - Xaa Xaa Xaa Xaa Thr Tyr Leu Ser Leu Asp As - #p Ser Gly Val Ser Leu 20 - # 25 - # 30 - - Met Xaa Lys Xaa Asp Xaa Asp Ile Asp Asp Ty - #r Asn Leu Xaa Trp Phe 35 - # 40 - # 45 - - Leu Phe Pro Ile Asp Xaa Xaa Gln Tyr Ile Il - #e Thr Ser Tyr Xaa Ala 50 - # 55 - # 60 - - Asn Asn Cys Lys Val Trp Asn Val Xaa Asn As - #p Lys Ile Asn Val Ser 65 - #70 - #75 - #80 - - Thr Tyr Ser Ser Thr Asn Ser Xaa Gln Lys Tr - #p Gln Ile Lys Ala Xaa 85 - # 90 - # 95 - - Xaa Ser Ser Tyr Xaa Ile Gln Ser Xaa Asn Gl - #y Lys Val Leu Thr Ala 100 - # 105 - # 110 - - Gly Xaa Gly Gln Xaa Leu Gly Xaa Xaa Arg Le - #u Thr Asp Glu Xaa Xaa 115 - # 120 - # 125 - - Xaa Asn Xaa Asn Gln Gln Trp Asn Leu Thr Xa - #a Val Gln Thr Ile Gln 130 - # 135 - # 140 - - Leu Pro Xaa Lys Pro Xaa Ile Asp Xaa Lys Le - #u Lys Asp Xaa Pro Xaa 145 1 - #50 1 - #55 1 -#60 - - Tyr Ser Xaa Thr Gly Asn Ile Xaa Xaa Xaa Th - #r Xaa Pro Gln LeuMet 165 - # 170 - # 175 - - Gly Trp Thr Leu Xaa Pro Cys Ile Met Val As - #n Asp Xaa Xaa Ile Asp 180 - # 185 - # 190 - - Lys Asn Thr Gln Ile Lys Thr Thr Pro Tyr Ty - #r Ile Xaa Lys Lys Tyr 195 - # 200 - # 205 - - Xaa Tyr Trp Xaa Xaa Ala Xaa Gly Ser Asn Va - #l Xaa Leu Xaa Pro His 210 - # 215 - # 220 - - Xaa Lys Xaa Ser Tyr Xaa Tyr Glu Trp Gly Th - #r Glu Xaa Xaa Gln Lys 225 2 - #30 2 - #35 2 -#40 - - Thr Thr Ile Ile Asn Thr Xaa Gly Xaa Gln Il - #e Asn Ile Asp SerGly 245 - # 250 - # 255 - - Met Lys Phe Xaa Xaa Pro Glu Val Gly Gly Gl - #y Thr Xaa Xaa Ile Lys 260 - # 265 - # 270 - - Thr Gln Leu Xaa Glu Glu Leu Lys Xaa Glu Ty - #r Ser Xaa Glu Thr Lys 275 - # 280 - # 285 - - Ile Met Xaa Lys Tyr Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 290 - # 295 - # 300 - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 305 3 - #10 3 - #15 3 -#20 - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa XaaXaa 325 - # 330 - # 335 - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 340 - # 345 - # 350 - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 355 - # 360 - # 365 - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa Xaa 370 - # 375 - # 380 - - Xaa Xaa 385 - - - - (2) INFORMATION FOR SEQ ID NO:29: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: - - GNGAAGTNCA TATNGAAATN AATAATAC - # - # 28 - - - - (2) INFORMATION FOR SEQ ID NO:30: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2015 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30: - - ATTAATTTTA TGGAGGTTGA TATTTATGTC AGCTCGCGAA GTACACATTG AA -#ATAAACAA 60 - - TAAAACACGT CATACATTAC AATTAGAGGA TAAAACTAAA CTTAGCGGCG GT -#AGATGGCG 120 - - AACATCACCT ACAAATGTTG CTCGTGATAC AATTAAAACA TTTGTAGCAG AA -#TCACATGG 180 - - TTTTATGACA GGAGTAGAAG GTATTATATA TTTTAGTGTA AACGGAGACG CA -#GAAATTAG 240 - - TTTACATTTT GACAATCCTT ATATAGGTTC TAATAAATGT GATGGTTCTT CT -#GATAAACC 300 - - TGAATATGAA GTTATTACTC AAAGCGGATC AGGAGATAAA TCTCATGTGA CA -#TATACTAT 360 - - TCAGACAGTA TCTTTACGAT TATAAGGAAA ATTTATAAAA ACTGTATTTT TT -#ACTAAAAT 420 - - ACCAAAAAAT ACATATTTAT TTTTTGGTAT TTTCTAATAT GAAATATGAA TT -#ATAAAAAT 480 - - ATTAATAAAA AAGGTGATAA AAATTATGTT AGATACTAAT AAAGTTTATG AA -#ATAAGCAA 540 - - TCTTGCTAAT GGATTATATA CATCAACTTA TTTAAGTCTT GATGATTCAG GT -#GTTAGTTT 600 - - AATGAGTAAA AAGGATGAAG ATATTGATGA TTACAATTTA AAATGGTTTT TA -#TTTCCTAT 660 - - TGATAATAAT CAATATATTA TTACAAGCTA TGGAGCTAAT AATTGTAAAG TT -#TGGAATGT 720 - - TAAAAATGAT AAAATAAATG TTTCAACTTA TTCTTCAACA AACTCTGTAC AA -#AAATGGCA 780 - - AATAAAAGCT AAAGATTCTT CATATATAAT ACAAAGTGAT AATGGAAAGG TC -#TTAACAGC 840 - - AGGAGTAGGT CAATCTCTTG GAATAGTACG CCTAACTGAT GAATTTCCAG AG -#AATTCTAA 900 - - CCAACAATGG AATTTAACTC CTGTACAAAC AATTCAACTC CCACAAAAAC CT -#AAAATAGA 960 - - TGAAAAATTA AAAGATCATC CTGAATATTC AGAAACCGGA AATATAAATC CT -#AAAACAAC 1020 - - TCCTCAATTA ATGGGATGGA CATTAGTACC TTGTATTATG GTAAATGATT CA -#AAAATAGA 1080 - - TAAAAACACT CAAATTAAAA CTACTCCATA TTATATTTTT AAAAAATATA AA -#TACTGGAA 1140 - - TCTAGCAAAA GGAAGTAATG TATCTTTACT TCCACATCAA AAAAGATCAT AT -#GATTATGA 1200 - - ATGGGGTACA GAAAAAAATC AAAAAACAAC TATTATTAAT ACAGTAGGAT TG -#CAAATTAA 1260 - - TATAGATTCA GGAATGAAAT TTGAAGTACC AGAAGTAGGA GGAGGTACAG AA -#GACATAAA 1320 - - AACACAATTA ACTGAAGAAT TAAAAGTTGA ATATAGCACT GAAACCAAAA TA -#ATGACGAA 1380 - - ATATCAAGAA CACTCAGAGA TAGATAATCC AACTAATCAA CCAATGAATT CT -#ATAGGACT 1440 - - TCTTATTTAT ACTTCTTTAG AATTATATCG ATATAACGGT ACAGAAATTA AG -#ATAATGGA 1500 - - CATAGAAACT TCAGATCATG ATACTTACAC TCTTACTTCT TATCCAAATC AT -#AAAGAAGC 1560 - - ATTATTACTT CTCACAAACC ATTCGTATGA AGAAGTAGAA GAAATAACAA AA -#ATACCTAA 1620 - - GCATACACTT ATAAAATTGA AAAAACATTA TTTTAAAAAA TAAAAAACAT AA -#TATATAAA 1680 - - TGACTGATTA ATATCTCTCG AAAAGGTTCT GGTGCAAAAA TAGTGGGATA TG -#AAAAAAGC 1740 - - AAAAGATTCC TAACGGAATG GAACATTAGG CTGTTAAATC AAAAAGTTTA TT -#GATAAAAT 1800 - - ATATCTGCCT TTGGACAGAC TTCTCCCCTT GGAGAGTTTG TCCTTTTTTG AC -#CATATGCA 1860 - - TAGCTTCTAT TCCGGCAATC ATTTTTGTAG CTGTTTGCAA GGATTTTAAT CC -#AAGCATAT 1920 - - CCGAATACGC TTTTTGATAA CCGATGTCTT GTTCAATGAT ATTGTTTAAT AT -#TTTCACAC 1980 - - GAATTGGCTA CTGTGCGGTA TCCTGTCTCC TTTAT - #- # 2015 - - - - (2) INFORMATION FOR SEQ ID NO:31: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 360 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: - - ATGTCAGCTC GCGAAGTACA CATTGAAATA AACAATAAAA CACGTCATAC AT -#TACAATTA 60 - - GAGGATAAAA CTAAACTTAG CGGCGGTAGA TGGCGAACAT CACCTACAAA TG -#TTGCTCGT 120 - - GATACAATTA AAACATTTGT AGCAGAATCA CATGGTTTTA TGACAGGAGT AG -#AAGGTATT 180 - - ATATATTTTA GTGTAAACGG AGACGCAGAA ATTAGTTTAC ATTTTGACAA TC -#CTTATATA 240 - - GGTTCTAATA AATGTGATGG TTCTTCTGAT AAACCTGAAT ATGAAGTTAT TA -#CTCAAAGC 300 - - GGATCAGGAG ATAAATCTCA TGTGACATAT ACTATTCAGA CAGTATCTTT AC -#GATTATAA 360 - - - - (2) INFORMATION FOR SEQ ID NO:32: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 119 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: - - Met Ser Ala Arg Glu Val His Ile Glu Ile As - #n Asn Lys Thr ArgHis 1 5 - # 10 - # 15 - - Thr Leu Gln Leu Glu Asp Lys Thr Lys Leu Se - #r Gly Gly Arg Trp Arg 20 - # 25 - # 30 - - Thr Ser Pro Thr Asn Val Ala Arg Asp Thr Il - #e Lys Thr Phe Val Ala 35 - # 40 - # 45 - - Glu Ser His Gly Phe Met Thr Gly Val Glu Gl - #y Ile Ile Tyr Phe Ser 50 - # 55 - # 60 - - Val Asn Gly Asp Ala Glu Ile Ser Leu His Ph - #e Asp Asn Pro Tyr Ile 65 - #70 - #75 - #80 - - Gly Ser Asn Lys Cys Asp Gly Ser Ser Asp Ly - #s Pro Glu Tyr Glu Val 85 - # 90 - # 95 - - Ile Thr Gln Ser Gly Ser Gly Asp Lys Ser Hi - #s Val Thr Tyr Thr Ile 100 - # 105 - # 110 - - Gln Thr Val Ser Leu Arg Leu 115 - - - - (2) INFORMATION FOR SEQ ID NO:33: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (synthetic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33: - - CATGAGATTT ATCTCCTGAT CCGC - # - # 24 - - - - (2) INFORMATION FOR SEQ ID NO:34: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2230 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34: - - ACTATGACAA TGATTATGAC TGCTGATGAA TTAGCTTTAT CAATACCAGG AT -#ATTCTAAA 60 - - CCATCAAATA TAACAGGAGA TAAAAGTAAA CATACATTAT TTACTAATAT AA -#TTGGAGAT 120 - - ATTCAAATAA AAGATCAAGC AACATTTGGG GTTGTTTTTG ATCCCCCTCT TA -#ATCGTATT 180 - - TCAGGGGCTG AAGAATCAAG TAAGTTTATT GATGTATATT ATCCTTCTGA AG -#ATAGTAAC 240 - - CTTAAATATT ATCAATTTAT AAAAGTAGCA ATTGATTTTG ATATTAATGA AG -#ATTTTATT 300 - - AATTTTAATA ATCATGACAA TATAGGGATA TTTAATTTTG TTACACGAAA TT -#TTTTATTA 360 - - AATAATGAAA ATGATTAATA AAAAATTTAA TTTGTATAAT ATGTTTATTT TT -#TGAAAATT 420 - - GAATGCATAT ATTAATCGAG TATGTGTAAT AAATTTTAAT TTTATGGAGG TT -#GATATTTA 480 - - TGTCAGCACG TGAAGTACAC ATTGATGTAA ATAATAAGAC AGGTCATACA TT -#ACAATTAG 540 - - AAGATAAAAC AAAACTTGAT GGTGGTAGAT GGCGAACATC ACCTACAAAT GT -#TGCTAATG 600 - - ATCAAATTAA AACATTTGTA GCAGAATCAC ATGGTTTTAT GACAGGTACA GA -#AGGTACTA 660 - - TATATTATAG TATAAATGGA GAAGCAGAAA TTAGTTTATA TTTTGACAAT CC -#TTATTCAG 720 - - GTTCTAATAA ATATGATGGG CATTCCAATA AAAATCAATA TGAAGTTATT AC -#CCAAGGAG 780 - - GATCAGGAAA TCAATCTCAT GTTACGTATA CTATTCAAAC TGTATCTTCA CG -#ATATGGGA 840 - - ATAATTCATA AAAAAATATT TTTTTTTACG AAAATACCAA AAAAATTTTT TT -#GGTATTTT 900 - - CTAATATAAT TCATAAATAT TTTAATAATA AAATTATAAG AAAAGGTGAT AA -#ATATTATG 960 - - TTAGATACTA ATAAAATTTA TGAAATAAGT AATTATGCTA ATGGATTACA TG -#CAGCAACT 1020 - - TATTTAAGTT TAGATGATTC AGGTGTTAGT TTAATGAATA AAAATGATGA TG -#ATATTGAT 1080 - - GACTATAATT TAAGGTGGTT TTTATTTCCT ATTGATGATA ATCAATATAT TA -#TTACAAGC 1140 - - TACGCAGCGA ATAATTGTAA GGTTTGGAAT GTTAATAATG ATAAAATAAA TG -#TTTCAACT 1200 - - TATTCTTCAA CAAACTCGAT ACAGAAATGG CAAATAAAAG CTAATGCTTC TT -#CGTATGTA 1260 - - ATACAAAGTA ATAATGGGAA AGTTCTAACA GCAGGAACCG GTCAATCTCT TG -#GATTAATA 1320 - - CGTTTAACGG ATGAATCACC AGATAATCCC AATCAACAAT GGAATTTAAC TC -#CTGTACAA 1380 - - ACAATTCAAC TCCCACCAAA ACCTACAATA GATACAAAGT TAAAAGATTA CC -#CCAAATAT 1440 - - TCACAAACTG GCAATATAGA CAAGGGAACA CCTCCTCAAT TAATGGGATG GA -#CATTAATA 1500 - - CCTTGTATTA TGGTAAATGA TCCAAATATA GATAAAAACA CTCAAATCAA AA -#CTACTCCA 1560 - - TATTATATTT TAAAAAAATA TCAATATTGG CAACAAGCAG TAGGAAGTAA TG -#TAGCTTTA 1620 - - CGTCCGCATG AAAAAAAATC ATATGCTTAT GAGTGGGGTA CAGAAATAGA TC -#AAAAAACA 1680 - - ACTATCATTA ATACATTAGG ATTTCAGATT AATATAGATT CGGGAATGAA AT -#TTGATATA 1740 - - CCAGAAGTAG GTGGAGGTAC AGATGAAATA AAAACACAAT TAAACGAAGA AT -#TAAAAATA 1800 - - GAATATAGCC GTGAAACCAA AATAATGGAA AAATATCAGG AACAATCAGA GA -#TAGATAAT 1860 - - CCAACTGATC AATCAATGAA TTCTATAGGA TTCCTCACTA TTACTTCTTT AG -#AATTATAT 1920 - - CGATATAATG GTTCGGAAAT TAGTGTAATG AAAATTCAAA CTTCAGATAA TG -#ATACTTAC 1980 - - AATGTGACCT CTTATCCAGA TCATCAACAA GCTCTATTAC TTCTTACAAA TC -#ATTCATAT 2040 - - GAAGAAGTAG AAGAAATAAC AAATATTCCC AAAATATCAC TGAAAAAATT AA -#AAAAATAT 2100 - - TATTTTTAAA ACATAATTAT ATTTTGATAG CTTTTTAAAA ATAAAGATTG TT -#CAAAGTAA 2160 - - AATGAAAGAA AATCTTTTAT GAAACTTTAA TACAATAAAA GAGGAATATT TT -#CTTATAAG 2220 - - TACTTCCTTG - # - # - # 2230 - - - - (2) INFORMATION FOR SEQ ID NO:35: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 372 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: - - ATGTCAGCAC GTGAAGTACA CATTGATGTA AATAATAAGA CAGGTCATAC AT -#TACAATTA 60 - - GAAGATAAAA CAAAACTTGA TGGTGGTAGA TGGCGAACAT CACCTACAAA TG -#TTGCTAAT 120 - - GATCAAATTA AAACATTTGT AGCAGAATCA CATGGTTTTA TGACAGGTAC AG -#AAGGTACT 180 - - ATATATTATA GTATAAATGG AGAAGCAGAA ATTAGTTTAT ATTTTGACAA TC -#CTTATTCA 240 - - GGTTCTAATA AATATGATGG GCATTCCAAT AAAAATCAAT ATGAAGTTAT TA -#CCCAAGGA 300 - - GGATCAGGAA ATCAATCTCA TGTTACGTAT ACTATTCAAA CTGTATCTTC AC -#GATATGGG 360 - - AATAATTCAT AA - # - # - # 372 - - - - (2) INFORMATION FOR SEQ ID NO:36: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 123 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36: - - Met Ser Ala Arg Glu Val His Ile Asp Val As - #n Asn Lys Thr Gly His 1 5 - # 10 - # 15 - - Thr Leu Gln Leu Glu Asp Lys Thr Lys Leu As - #p Gly Gly Arg Trp Arg 20 - # 25 - # 30 - - Thr Ser Pro Thr Asn Val Ala Asn Asp Gln Il - #e Lys Thr Phe Val Ala 35 - # 40 - # 45 - - Glu Ser His Gly Phe Met Thr Gly Thr Glu Gl - #y Thr Ile Tyr Tyr Ser 50 - # 55 - # 60 - - Ile Asn Gly Glu Ala Glu Ile Ser Leu Tyr Ph - #e Asp Asn Pro Tyr Ser 65 - #70 - #75 - #80 - - Gly Ser Asn Lys Tyr Asp Gly His Ser Asn Ly - #s Asn Gln Tyr Glu Val 85 - # 90 - # 95 - - Ile Thr Gln Gly Gly Ser Gly Asn Gln Ser Hi - #s Val Thr Tyr Thr Ile 100 - # 105 - # 110 - - Gln Thr Val Ser Ser Arg Tyr Gly Asn Asn Se - #r 115 - # 120 - - - - (2) INFORMATION FOR SEQ ID NO:37: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1152 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37: - - ATGTTAGATA CTAATAAAAT TTATGAAATA AGTAATTATG CTAATGGATT AC -#ATGCAGCA 60 - - ACTTATTTAA GTTTAGATGA TTCAGGTGTT AGTTTAATGA ATAAAAATGA TG -#ATGATATT 120 - - GATGACTATA ATTTAAGGTG GTTTTTATTT CCTATTGATG ATAATCAATA TA -#TTATTACA 180 - - AGCTACGCAG CGAATAATTG TAAGGTTTGG AATGTTAATA ATGATAAAAT AA -#ATGTTTCA 240 - - ACTTATTCTT CAACAAACTC GATACAGAAA TGGCAAATAA AAGCTAATGC TT -#CTTCGTAT 300 - - GTAATACAAA GTAATAATGG GAAAGTTCTA ACAGCAGGAA CCGGTCAATC TC -#TTGGATTA 360 - - ATACGTTTAA CGGATGAATC ACCAGATAAT CCCAATCAAC AATGGAATTT AA -#CTCCTGTA 420 - - CAAACAATTC AACTCCCACC AAAACCTACA ATAGATACAA AGTTAAAAGA TT -#ACCCCAAA 480 - - TATTCACAAA CTGGCAATAT AGACAAGGGA ACACCTCCTC AATTAATGGG AT -#GGACATTA 540 - - ATACCTTGTA TTATGGTAAA TGATCCAAAT ATAGATAAAA ACACTCAAAT CA -#AAACTACT 600 - - CCATATTATA TTTTAAAAAA ATATCAATAT TGGCAACAAG CAGTAGGAAG TA -#ATGTAGCT 660 - - TTACGTCCGC ATGAAAAAAA ATCATATGCT TATGAGTGGG GTACAGAAAT AG -#ATCAAAAA 720 - - ACAACTATCA TTAATACATT AGGATTTCAG ATTAATATAG ATTCGGGAAT GA -#AATTTGAT 780 - - ATACCAGAAG TAGGTGGAGG TACAGATGAA ATAAAAACAC AATTAAACGA AG -#AATTAAAA 840 - - ATAGAATATA GCCGTGAAAC CAAAATAATG GAAAAATATC AGGAACAATC AG -#AGATAGAT 900 - - AATCCAACTG ATCAATCAAT GAATTCTATA GGATTCCTCA CTATTACTTC TT -#TAGAATTA 960 - - TATCGATATA ATGGTTCGGA AATTAGTGTA ATGAAAATTC AAACTTCAGA TA -#ATGATACT 1020 - - TACAATGTGA CCTCTTATCC AGATCATCAA CAAGCTCTAT TACTTCTTAC AA -#ATCATTCA 1080 - - TATGAAGAAG TAGAAGAAAT AACAAATATT CCCAAAATAT CACTGAAAAA AT -#TAAAAAAA 1140 - - TATTATTTTT AA - # - # - # 1152 - - - - (2) INFORMATION FOR SEQ ID NO:38: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 383 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38: - - Met Leu Asp Thr Asn Lys Ile Tyr Glu Ile Se - #r Asn Tyr Ala Asn Gly 1 5 - # 10 - # 15 - - Leu His Ala Ala Thr Tyr Leu Ser Leu Asp As - #p Ser Gly Val Ser Leu 20 - # 25 - # 30 - - Met Asn Lys Asn Asp Asp Asp Ile Asp Asp Ty - #r Asn Leu Arg Trp Phe 35 - # 40 - # 45 - - Leu Phe Pro Ile Asp Asp Asn Gln Tyr Ile Il - #e Thr Ser Tyr Ala Ala 50 - # 55 - # 60 - - Asn Asn Cys Lys Val Trp Asn Val Asn Asn As - #p Lys Ile Asn Val Ser 65 - #70 - #75 - #80 - - Thr Tyr Ser Ser Thr Asn Ser Ile Gln Lys Tr - #p Gln Ile Lys Ala Asn 85 - # 90 - # 95 - - Ala Ser Ser Tyr Val Ile Gln Ser Asn Asn Gl - #y Lys Val Leu Thr Ala 100 - # 105 - # 110 - - Gly Thr Gly Gln Ser Leu Gly Leu Ile Arg Le - #u Thr Asp Glu Ser Pro 115 - # 120 - # 125 - - Asp Asn Pro Asn Gln Gln Trp Asn Leu Thr Pr - #o Val Gln Thr Ile Gln 130 - # 135 - # 140 - - Leu Pro Pro Lys Pro Thr Ile Asp Thr Lys Le - #u Lys Asp Tyr Pro Lys 145 1 - #50 1 - #55 1 -#60 - - Tyr Ser Gln Thr Gly Asn Ile Asp Lys Gly Th - #r Pro Pro Gln LeuMet 165 - # 170 - # 175 - - Gly Trp Thr Leu Ile Pro Cys Ile Met Val As - #n Asp Pro Asn Ile Asp 180 - # 185 - # 190 - - Lys Asn Thr Gln Ile Lys Thr Thr Pro Tyr Ty - #r Ile Leu Lys Lys Tyr 195 - # 200 - # 205 - - Gln Tyr Trp Gln Gln Ala Val Gly Ser Asn Va - #l Ala Leu Arg Pro His 210 - # 215 - # 220 - - Glu Lys Lys Ser Tyr Ala Tyr Glu Trp Gly Th - #r Glu Ile Asp Gln Lys 225 2 - #30 2 - #35 2 -#40 - - Thr Thr Ile Ile Asn Thr Leu Gly Phe Gln Il - #e Asn Ile Asp SerGly 245 - # 250 - # 255 - - Met Lys Phe Asp Ile Pro Glu Val Gly Gly Gl - #y Thr Asp Glu Ile Lys 260 - # 265 - # 270 - - Thr Gln Leu Asn Glu Glu Leu Lys Ile Glu Ty - #r Ser Arg Glu Thr Lys 275 - # 280 - # 285 - - Ile Met Glu Lys Tyr Gln Glu Gln Ser Glu Il - #e Asp Asn Pro Thr Asp 290 - # 295 - # 300 - - Gln Ser Met Asn Ser Ile Gly Phe Leu Thr Il - #e Thr Ser Leu Glu Leu 305 3 - #10 3 - #15 3 -#20 - - Tyr Arg Tyr Asn Gly Ser Glu Ile Ser Val Me - #t Lys Ile Gln ThrSer 325 - # 330 - # 335 - - Asp Asn Asp Thr Tyr Asn Val Thr Ser Tyr Pr - #o Asp His Gln Gln Ala 340 - # 345 - # 350 - - Leu Leu Leu Leu Thr Asn His Ser Tyr Glu Gl - #u Val Glu Glu Ile Thr 355 - # 360 - # 365 - - Asn Ile Pro Lys Ile Ser Leu Lys Lys Leu Ly - #s Lys Tyr Tyr Phe 370 - # 375 - # 380 - - - - (2) INFORMATION FOR SEQ ID NO:39: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2132 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39: - - GTATTTCAGG GGGTGAAGAT TCAAGTAAGT TTATTGATGT ATATTATCCT TT -#TGAAGATA 60 - - GTAATTTTAA ATATTATCAA TTTATAAAAG TAGCAATTGA TTTTGATATT AA -#TGAAGATT 120 - - TTATTAATTT TAATAATCAT GACAATATAG GGATATTTAA TTTTGTTACA CG -#AAATTTTT 180 - - TATTAAATAA TGAAAATGAT GAATAAAAAA TTTAATTTGT TTATTATGTT TA -#TTTTTTGA 240 - - AAATTGAATG CATATATTAA TCGAGTATGT ATAATAAATT TTAATTTTAT GG -#AGGTTGAT 300 - - ATTTATGTCA GCACGTGAAG TACACATTGA TGTAAATAAT AAGACAGGTC AT -#ACATTACA 360 - - ATTAGAAGAT AAAACAAAAC TTGATGGTGG TAGATGGCGA ACATCACCTA CA -#AATGTTGC 420 - - TAATGATCAA ATTAAAACAT TTGTAGCAGA ATCAAATGGT TTTATGACAG GT -#ACAGAAGG 480 - - TACTATATAT TATAGTATAA ATGGAGAAGC AGAAATTAGT TTATATTTTG AC -#AATCCTTT 540 - - TGCAGGTTCT AATAAATATG ATGGACATTC CAATAAATCT CAATATGAAA TT -#ATTACCCA 600 - - AGGAGGATCA GGAAATCAAT CTCATGTTAC GTATACTATT CAAACCACAT CC -#TCACGATA 660 - - TGGGCATAAA TCATAACAAA TAATTTTTTA CGAAAATACC AAAAAATAAA TA -#TTTTTTGG 720 - - TATTTTCTAA TATAAATTAC AAATATATTA ATAATAAAAT TATAAGAAAA GG -#TGATAAAG 780 - - ATTATGTTAG ATACTAATAA AGTTTATGAA ATAAGCAATC ATGCTAATGG AC -#TATATGCA 840 - - GCAACTTATT TAAGTTTAGA TGATTCAGGT GTTAGTTTAA TGAATAAAAA TG -#ATGATGAT 900 - - ATTGATGATT ATAACTTAAA ATGGTTTTTA TTTCCTATTG ATGATGATCA AT -#ATATTATT 960 - - ACAAGCTATG CAGCAAATAA TTGTAAAGTT TGGAATGTTA ATAATGATAA AA -#TAAATGTT 1020 - - TCGACTTATT CTTCAACAAA TTCAATACAA AAATGGCAAA TAAAAGCTAA TG -#GTTCTTCA 1080 - - TATGTAATAC AAAGTGATAA TGGAAAAGTC TTAACAGCAG GAACCGGTCA AG -#CTCTTGGA 1140 - - TTGATACGTT TAACTGATGA ATCCTCAAAT AATCCCAATC AACAATGGAA TT -#TAACTTCT 1200 - - GTACAAACAA TTCAACTTCC ACAAAAACCT ATAATAGATA CAAAATTAAA AG -#ATTATCCC 1260 - - AAATATTCAC CAACTGGAAA TATAGATAAT GGAACATCTC CTCAATTAAT GG -#GATGGACA 1320 - - TTAGTACCTT GTATTATGGT AAATGATCCA AATATAGATA AAAATACTCA AA -#TTAAAACT 1380 - - ACTCCATATT ATATTTTAAA AAAATATCAA TATTGGCAAC GAGCAGTAGG AA -#GTAATGTA 1440 - - GCTTTACGTC CACATGAAAA AAAATCATAT ACTTATGAAT GGGGCACAGA AA -#TAGATCAA 1500 - - AAAACAACAA TTATAAATAC ATTAGGATTT CAAATCAATA TAGATTCAGG AA -#TGAAATTT 1560 - - GATATACCAG AAGTAGGTGG AGGTACAGAT GAAATAAAAA CACAACTAAA TG -#AAGAATTA 1620 - - AAAATAGAAT ATAGTCATGA AACTAAAATA ATGGAAAAAT ATCAAGAACA AT -#CTGAAATA 1680 - - GATAATCCAA CTGATCAATC AATGAATTCT ATAGGATTTC TTACTATTAC TT -#CCTTAGAA 1740 - - TTATATAGAT ATAATGGCTC AGAAATTCGT ATAATGCAAA TTCAAACCTC AG -#ATAATGAT 1800 - - ACTTATAATG TTACTTCTTA TCCAAATCAT CAACAAGCTT TATTACTTCT TA -#CAAATCAT 1860 - - TCATATGAAG AAGTAGAAGA AATAACAAAT ATTCCTAAAA GTACACTAAA AA -#AATTAAAA 1920 - - AAATATTATT TTTAAATATT GAAATTAGAA ATTATCTAAA ACAAAACGAA AG -#ATAATTTA 1980 - - ATCTTTAATT ATTTGTAAGA TAATCGTATT TTATTTGTAT TAATTTTTAT AC -#AATATAAA 2040 - - GTAATATCTG TACGTGAAAT TGGTTTCGCT TCAATATCTA ATCTCATCTC AT -#GTATTACA 2100 - - TGCGTAATAC CTTCTTGTTC TGCTTCTACA AG - # - # 2132 - - - - (2) INFORMATION FOR SEQ ID NO:40: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 372 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40: - - ATGTCAGCAC GTGAAGTACA CATTGATGTA AATAATAAGA CAGGTCATAC AT -#TACAATTA 60 - - GAAGATAAAA CAAAACTTGA TGGTGGTAGA TGGCGAACAT CACCTACAAA TG -#TTGCTAAT 120 - - GATCAAATTA AAACATTTGT AGCAGAATCA AATGGTTTTA TGACAGGTAC AG -#AAGGTACT 180 - - ATATATTATA GTATAAATGG AGAAGCAGAA ATTAGTTTAT ATTTTGACAA TC -#CTTTTGCA 240 - - GGTTCTAATA AATATGATGG ACATTCCAAT AAATCTCAAT ATGAAATTAT TA -#CCCAAGGA 300 - - GGATCAGGAA ATCAATCTCA TGTTACGTAT ACTATTCAAA CCACATCCTC AC -#GATATGGG 360 - - CATAAATCAT AA - # - # - # 372 - - - - (2) INFORMATION FOR SEQ ID NO:41: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 123 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41: - - Met Ser Ala Arg Glu Val His Ile Asp Val As - #n Asn Lys Thr Gly His 1 5 - # 10 - # 15 - - Thr Leu Gln Leu Glu Asp Lys Thr Lys Leu As - #p Gly Gly Arg Trp Arg 20 - # 25 - # 30 - - Thr Ser Pro Thr Asn Val Ala Asn Asp Gln Il - #e Lys Thr Phe Val Ala 35 - # 40 - # 45 - - Glu Ser Asn Gly Phe Met Thr Gly Thr Glu Gl - #y Thr Ile Tyr Tyr Ser 50 - # 55 - # 60 - - Ile Asn Gly Glu Ala Glu Ile Ser Leu Tyr Ph - #e Asp Asn Pro Phe Ala 65 - #70 - #75 - #80 - - Gly Ser Asn Lys Tyr Asp Gly His Ser Asn Ly - #s Ser Gln Tyr Glu Ile 85 - # 90 - # 95 - - Ile Thr Gln Gly Gly Ser Gly Asn Gln Ser Hi - #s Val Thr Tyr Thr Ile 100 - # 105 - # 110 - - Gln Thr Thr Ser Ser Arg Tyr Gly His Lys Se - #r 115 - # 120 - - - - (2) INFORMATION FOR SEQ ID NO:42: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1152 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42: - - ATGTTAGATA CTAATAAAGT TTATGAAATA AGCAATCATG CTAATGGACT AT -#ATGCAGCA 60 - - ACTTATTTAA GTTTAGATGA TTCAGGTGTT AGTTTAATGA ATAAAAATGA TG -#ATGATATT 120 - - GATGATTATA ACTTAAAATG GTTTTTATTT CCTATTGATG ATGATCAATA TA -#TTATTACA 180 - - AGCTATGCAG CAAATAATTG TAAAGTTTGG AATGTTAATA ATGATAAAAT AA -#ATGTTTCG 240 - - ACTTATTCTT CAACAAATTC AATACAAAAA TGGCAAATAA AAGCTAATGG TT -#CTTCATAT 300 - - GTAATACAAA GTGATAATGG AAAAGTCTTA ACAGCAGGAA CCGGTCAAGC TC -#TTGGATTG 360 - - ATACGTTTAA CTGATGAATC CTCAAATAAT CCCAATCAAC AATGGAATTT AA -#CTTCTGTA 420 - - CAAACAATTC AACTTCCACA AAAACCTATA ATAGATACAA AATTAAAAGA TT -#ATCCCAAA 480 - - TATTCACCAA CTGGAAATAT AGATAATGGA ACATCTCCTC AATTAATGGG AT -#GGACATTA 540 - - GTACCTTGTA TTATGGTAAA TGATCCAAAT ATAGATAAAA ATACTCAAAT TA -#AAACTACT 600 - - CCATATTATA TTTTAAAAAA ATATCAATAT TGGCAACGAG CAGTAGGAAG TA -#ATGTAGCT 660 - - TTACGTCCAC ATGAAAAAAA ATCATATACT TATGAATGGG GCACAGAAAT AG -#ATCAAAAA 720 - - ACAACAATTA TAAATACATT AGGATTTCAA ATCAATATAG ATTCAGGAAT GA -#AATTTGAT 780 - - ATACCAGAAG TAGGTGGAGG TACAGATGAA ATAAAAACAC AACTAAATGA AG -#AATTAAAA 840 - - ATAGAATATA GTCATGAAAC TAAAATAATG GAAAAATATC AAGAACAATC TG -#AAATAGAT 900 - - AATCCAACTG ATCAATCAAT GAATTCTATA GGATTTCTTA CTATTACTTC CT -#TAGAATTA 960 - - TATAGATATA ATGGCTCAGA AATTCGTATA ATGCAAATTC AAACCTCAGA TA -#ATGATACT 1020 - - TATAATGTTA CTTCTTATCC AAATCATCAA CAAGCTTTAT TACTTCTTAC AA -#ATCATTCA 1080 - - TATGAAGAAG TAGAAGAAAT AACAAATATT CCTAAAAGTA CACTAAAAAA AT -#TAAAAAAA 1140 - - TATTATTTTT AA - # - # - # 1152 - - - - (2) INFORMATION FOR SEQ ID NO:43: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 383 amino - #acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: protein - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43: - - Met Leu Asp Thr Asn Lys Val Tyr Glu Ile Se - #r Asn His Ala Asn Gly 1 5 - # 10 - # 15 - - Leu Tyr Ala Ala Thr Tyr Leu Ser Leu Asp As - #p Ser Gly Val Ser Leu 20 - # 25 - # 30 - - Met Asn Lys Asn Asp Asp Asp Ile Asp Asp Ty - #r Asn Leu Lys Trp Phe 35 - # 40 - # 45 - - Leu Phe Pro Ile Asp Asp Asp Gln Tyr Ile Il - #e Thr Ser Tyr Ala Ala 50 - # 55 - # 60 - - Asn Asn Cys Lys Val Trp Asn Val Asn Asn As - #p Lys Ile Asn Val Ser 65 - #70 - #75 - #80 - - Thr Tyr Ser Ser Thr Asn Ser Ile Gln Lys Tr - #p Gln Ile Lys Ala Asn 85 - # 90 - # 95 - - Gly Ser Ser Tyr Val Ile Gln Ser Asp Asn Gl - #y Lys Val Leu Thr Ala 100 - # 105 - # 110 - - Gly Thr Gly Gln Ala Leu Gly Leu Ile Arg Le - #u Thr Asp Glu Ser Ser 115 - # 120 - # 125 - - Asn Asn Pro Asn Gln Gln Trp Asn Leu Thr Se - #r Val Gln Thr Ile Gln 130 - # 135 - # 140 - - Leu Pro Gln Lys Pro Ile Ile Asp Thr Lys Le - #u Lys Asp Tyr Pro Lys 145 1 - #50 1 - #55 1 -#60 - - Tyr Ser Pro Thr Gly Asn Ile Asp Asn Gly Th - #r Ser Pro Gln LeuMet 165 - # 170 - # 175 - - Gly Trp Thr Leu Val Pro Cys Ile Met Val As - #n Asp Pro Asn Ile Asp 180 - # 185 - # 190 - - Lys Asn Thr Gln Ile Lys Thr Thr Pro Tyr Ty - #r Ile Leu Lys Lys Tyr 195 - # 200 - # 205 - - Gln Tyr Trp Gln Arg Ala Val Gly Ser Asn Va - #l Ala Leu Arg Pro His 210 - # 215 - # 220 - - Glu Lys Lys Ser Tyr Thr Tyr Glu Trp Gly Th - #r Glu Ile Asp Gln Lys 225 2 - #30 2 - #35 2 -#40 - - Thr Thr Ile Ile Asn Thr Leu Gly Phe Gln Il - #e Asn Ile Asp SerGly 245 - # 250 - # 255 - - Met Lys Phe Asp Ile Pro Glu Val Gly Gly Gl - #y Thr Asp Glu Ile Lys 260 - # 265 - # 270 - - Thr Gln Leu Asn Glu Glu Leu Lys Ile Glu Ty - #r Ser His Glu Thr Lys 275 - # 280 - # 285 - - Ile Met Glu Lys Tyr Gln Glu Gln Ser Glu Il - #e Asp Asn Pro Thr Asp 290 - # 295 - # 300 - - Gln Ser Met Asn Ser Ile Gly Phe Leu Thr Il - #e Thr Ser Leu Glu Leu 305 3 - #10 3 - #15 3 -#20 - - Tyr Arg Tyr Asn Gly Ser Glu Ile Arg Ile Me - #t Gln Ile Gln ThrSer 325 - # 330 - # 335 - - Asp Asn Asp Thr Tyr Asn Val Thr Ser Tyr Pr - #o Asn His Gln Gln Ala 340 - # 345 - # 350 - - Leu Leu Leu Leu Thr Asn His Ser Tyr Glu Gl - #u Val Glu Glu Ile Thr 355 - # 360 - # 365 - - Asn Ile Pro Lys Ser Thr Leu Lys Lys Leu Ly - #s Lys Tyr Tyr Phe 370 - # 375 - # 380 - - - - (2) INFORMATION FOR SEQ ID NO:44: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 360 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44: - - ATGTCCGCCC GCGAGGTGCA CATCGAGATC AACAACAAGA CCCGCCACAC CC -#TCCAGCTC 60 - - GAGGACAAGA CCAAGCTCTC CGGCGGCAGG TGGCGCACCT CCCCGACCAA CG -#TGGCCCGC 120 - - GACACCATCA AGACGTTCGT GGCGGAGTCC CACGGCTTCA TGACCGGCGT CG -#AGGGCATC 180 - - ATCTACTTCT CCGTGAACGG CGACGCCGAG ATCTCCCTCC ACTTCGACAA CC -#CGTACATC 240 - - GGCTCCAACA AGTGCGACGG CTCCTCCGAC AAGCCCGAGT ACGAGGTGAT CA -#CCCAGTCC 300 - - GGCTCCGGCG ACAAGTCCCA CGTGACCTAC ACCATCCAGA CCGTGTCCCT CC -#GCCTCTGA 360 - - - - (2) INFORMATION FOR SEQ ID NO:45: - - (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1158 base - #pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear - - (ii) MOLECULE TYPE: DNA (genomic) - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45: - - ATGCTCGACA CCAACAAGGT GTACGAGATC TCCAACCTCG CCAACGGCCT CT -#ACACCTCC 60 - - ACCTACCTCT CCCTCGACGA CTCCGGCGTG TCCCTCATGT CCAAGAAGGA CG -#AGGACATC 120 - - GACGACTACA ACCTCAAGTG GTTCCTCTTC CCGATCGACA ACAACCAGTA CA -#TCATCACC 180 - - TCCTACGGCG CCAACAACTG CAAGGTGTGG AACGTGAAGA ACGACAAGAT CA -#ACGTGTCC 240 - - ACCTACTCCT CCACCAACTC CGTGCAGAAG TGGCAGATCA AGGCCAAGGA CT -#CCTCCTAC 300 - - ATCATCCAGT CCGACAACGG CAAGGTGCTC ACCGCGGGCG TGGGCCAGTC CC -#TCGGCATC 360 - - GTGCGCCTCA CCGACGAGTT CCCGGAGAAC TCCAACCAGC AATGGAACCT CA -#CCCCGGTG 420 - - CAGACCATCC AGCTCCCGCA GAAGCCGAAG ATCGACGAGA AGCTCAAGGA CC -#ACCCGGAG 480 - - TACTCCGAGA CCGGCAACAT CAACCCGAAG ACCACCCCGC AGCTCATGGG CT -#GGACCCTC 540 - - GTGCCGTGCA TCATGGTGAA CGACTCCAAG ATCGACAAGA ACACCCAGAT CA -#AGACCACC 600 - - CCGTACTACA TCTTCAAGAA ATACAAGTAC TGGAACCTCG CCAAGGGCTC CA -#ACGTGTCC 660 - - CTCCTCCCGC ACCAGAAGCG CAGCTACGAC TACGAGTGGG GCACCGAGAA GA -#ACCAGAAG 720 - - ACCACCATCA TCAACACCGT GGGCCTGCAG ATCAACATCG ACTCGGGGAT GA -#AGTTCGAG 780 - - GTGCCGGAGG TGGGCGGCGG CACCGAGGAC ATCAAGACCC AGCTCACCGA GG -#AGCTGAAG 840 - - GTGGAGTACT CCACCGAGAC CAAGATCATG ACCAAGTACC AGGAGCACTC CG -#AGATCGAC 900 - - AACCCGACCA ACCAGCCGAT GAACTCCATC GGCCTCCTCA TCTACACCTC CC -#TCGAGCTG 960 - - TACCGCTACA ACGGCACCGA GATCAAGATC ATGGACATCG AGACCTCCGA CC -#ACGACACC 1020 - - TACACCCTCA CCTCCTACCC GAACCACAAG GAGGCGCTGC TGCTGCTGAC CA -#ACCACTCC 1080 - - TACGAGGAGG TGGAGGAGAT CACCAAGATC CCGAAGCACA CCCTCATCAA GC -#TCAAGAAG 1140 - - CACTACTTCA AGAAGTGA - # - # - #1158__________________________________________________________________________

Claims

1. An isolated polynucleotide which encodes a Bacillus toxin active against a non-mammalian pest, wherein said toxin has a molecular weight between approximately 10 kDa and approximately 15 kDa toxin, and wherein a nucleotide sequence selected from the group consisting of SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 40, and SEQ ID NO. 44 hybridizes under stringent conditions with said polynucleotide.
2. The polynucleotide according to claim 1 wherein said toxin is active against a coleopteran pest.
3. The polynucleotide according to claim 1 wherein said toxin is active against corn rootworm.
4. The polynucleotide according to claim 1 wherein said toxin is active against western corn rootworm.
5. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 29.
6. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 31.
7. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 33.
8. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 35.
9. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 40.
10. The polynucleotide according to claim 2 wherein said nucleotide sequence is SEQ ID NO. 44.
11. An isolated polynucleotide comprising a nucleotide sequence which encodes a toxin active against a non-mammalian pest wherein said toxin comprises a pesticidal portion of an amino acid sequence encoded by the nucleotide sequence shown in the group selected from SEQ ID NO. 30, SEQ ID NO. 34, and SEQ ID NO. 39.
12. The polynucleotide according to claim 11 wherein said nucleotide sequence is SEQ ID NO. 30.
13. The polynucleotide according to claim 11 wherein said nucleotide sequence is SEQ ID NO. 34.
14. The polynucleotide according to claim 11 wherein said nucleotide sequence is SEQ ID NO. 39.
15. The polynucleotide according to claim 11 wherein said toxin comprises an amino acid sequence encoded by SEQ ID NO. 30.
16. The polynucleotide according to claim 11 wherein said toxin comprises an amino acid sequence encoded by SEQ ID NO. 34.
17. The polynucleotide according to claim 11 wherein said toxin comprises an amino acid sequence encoded by SEQ ID NO. 39.
18. The polynucleotide according to claim 11 wherein said toxin is approximately 10-15 kDa.
19. An isolated polynucleotide comprising a nucleotide sequence which encodes a toxin which is active against a non-mammalian pest, wherein said nucleotide sequence is from a Bacillus thuringiensis isolate selected from the group consisting of PS149B1, having the identifying characteristics of NRRL B-21553; and PS167H2, having the identifying characteristics of NRRL B-21554.
20. The isolated polynucleotide according to claim 19 wherein said toxin is approximately 10-15 kDa.
21. The isolated polynucleotide according to claim 19 wherein said isolate is PS149B1, having the identifying characteristics of NRRL B-21553.
22. The isolated polynucleotide according to claim 19 wherein said isolate is PS167H2, having the identifying characteristics of NRRL B-21554.
23. The isolated polynucleotide according to claim 21 wherein said toxin is approximately 10-15 kDa.
24. The isolated polynucleotide according to claim 22 wherein said toxin is approximately 10-15 kDa.
25. An isolated polynucleotide comprising a nucleotide sequence which encodes a toxin which is active against a non-mammalian pest, wherein said toxin is from Bacillus thuringiensis isolate PS80JJ1, having the identifying characteristics of NRRL B-18679; and wherein said toxin is approximately 10-15 kDa.
26. An isolated polynucleotide comprising a nucleotide sequence which encodes a toxin active against a non-mammalian pest wherein said toxin comprises a pesticidal portion of an amino acid sequence selected from the group consisting of SEQ ID NO. 32, SEQ ID NO. 36, and SEQ ID NO. 41.
27. The isolated polynucleotide, according to claim 26, wherein said toxin comprises the amino acid sequence shown in SEQ ID NO. 32.
28. The isolated polynucleotide, according to claim 26, wherein said nucleotide sequence encodes a toxin of approximately 10-15 kDa.
29. The polynucleotide of claim 26 wherein said toxin comprises a pesticidal portion of the amino acid sequence shown in SEQ ID NO. 32.
30. The polynucleotide of claim 26 wherein said toxin comprises a pesticidal portion of the amino acid sequence shown in SEQ ID NO. 36.
31. The polynucleotide of claim 26 wherein said toxin comprises a pesticidal portion of the amino acid sequence shown in SEQ ID NO. 41.
32. The isolated polynucleotide, according to claim 26, wherein said toxin comprises the amino acid sequence shown in SEQ ID NO. 36.
33. The isolated polynucleotide, according to claim 26, wherein said toxin comprises the amino acid sequence shown in SEQ ID NO. 41.
34. The polynucleotide of claim 26 wherein said polynucleotide comprises a nucleotide sequence selected from the group consisting of SEQ ID NO. 31, SEQ ID NO. 35, SEQ ID NO. 40, and fragments of the foregoing that are sufficient to encode an active toxin.
35. The polynucleotide of claim 26 wherein said polynucleotide comprises a fragment of SEQ ID NO. 31 that is sufficient to encode an active toxin.
36. The polynucleotide of claim 26 wherein said polynucleotide comprises the nucleotide sequence shown in SEQ ID NO. 31.
37. The polynucleotide of claim 26 wherein said polynucleotide comprises a fragment of SEQ ID NO. 35 that is sufficient to encode an active toxin.
38. The polynucleotide of claim 26 wherein said polynucleotide comprises the nucleotide sequence shown in SEQ ID NO. 35.
39. The polynucleotide of claim 26 wherein said polynucleotide comprises a fragment of SEQ ID NO. 40 that is sufficient to encode an active toxin.
40. The polynucleotide of claim 26 wherein said polynucleotide comprises the nucleotide sequence shown in SEQ ID NO. 40.
41. A polynucleotide comprising a nucleotide sequence which encodes an approximately 10-15 kDa 80JJ1 toxin active against a coleopteran pest, wherein said nucleotide sequence has been optimized for expression in plants, and wherein said toxin comprises the amino acid sequence shown in SEQ ID NO. 32.
42. An isolated polynucleotide that comprises the sequence shown in SEQ ID NO. 44.
43. A polynucleotide comprising a nucleotide sequence which encodes an approximately 10-15 kDa polypeptide, wherein said nucleotide sequence is optimized for expression in plants, and wherein said polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO. 36 and SEQ ID NO. 41.
44. The polynucleotide according to claim 43 wherein said amino acid sequence is SEQ ID NO. 36.
45. The polynucleotide according to claim 43 wherein said amino acid sequence is SEQ ID NO. 41.
46. A recombinant host that expresses at least a first polynucleotide, which encodes a first pesticidally active Bacillus polypeptide, and a second polynucleotide, which encodes a second pesticidally active Bacillus polypeptide, wherein said first polypeptide has a molecular weight between approximately 10 kDa and approximately 15 kDa, and wherein said first polynucleotide hybridizes under stringent conditions to a nucleotide sequence selected from the group consisting of SEQ ID NO: 29, SEQ ID NO: 31, SEQ ID NO: 33, SEQ ID NO: 35, SEQ ID NO: 40, and SEQ ID NO: 44; and wherein said second polypeptide has a molecular weight between approximately 40 kDa and approximately 50 kDa, and wherein said second polynucleotide hybridizes under stringent conditions to a nucleotide sequence selected from the group consisting of SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 12; SEQ ID NO: 14, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 37, SEQ ID NO: 42 and SEQ ID NO: 45.
47. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 29.
48. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 31.
49. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 33.
50. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 35.
51. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 40.
52. The recombinant host of claim 46 wherein said first polynucleotide hybridizes under stringent conditions to SEQ ID NO. 44.
53. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 8.
54. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 9.
55. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 10.
56. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 12.
57. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 14.
58. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 20.
59. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 21.
60. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 22.
61. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 23.
62. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 24.
63. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 25.
64. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 26.
65. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 27.
66. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 37.
67. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 42.
68. The recombinant host of claim 46 wherein said second polynucleotide hybridizes under stringent conditions to SEQ ID NO. 45.
69. A recombinant host comprising a polynucleotide sequence which encodes a polypeptide comprising a pesticidal portion of an amino acid sequence selected from the group consisting of SEQ ID NO. 32, SEQ ID NO. 36, and SEQ ID NO. 41.
70. The recombinant host according to claim 69 wherein said amino acid sequence is shown in SEQ ID NO. 32.
71. The recombinant host according to claim 69 wherein said polypeptide comprises the amino acid sequence shown in SEQ ID NO. 32.
72. The recombinant host according to claim 69 wherein said amino acid sequence is shown in SEQ ID NO. 36.
73. The recombinant host according to claim 69 wherein said polypeptide comprises the amino acid sequence shown in SEQ ID NO. 36.
74. The recombinant host according to claim 69 wherein said amino acid sequence is shown in SEQ ID NO. 41.
75. The recombinant host according to claim 69 wherein said polypeptide comprises the amino acid sequence shown in SEQ ID NO. 41.
76. A recombinant host that express a polynucleotide encoding a pesticidal polypeptide wherein said polynucleotide comprises a nucleotide sequence shown in a sequence selected from the group consisting of SEQ ID NO. 31, SEQ ID NO. 35, and SEQ ID NO. 40, SEQ ID NO. 44, and fragments of the foregoing that are sufficient to encode a pesticidal polypeptide.
77. The recombinant host according to claim 76 wherein said polynucleotide comprises a pesticidal portion of the nucleotide sequence is shown in SEQ ID NO. 31.
78. The recombinant host according to claim 76 wherein said polynucleotide comprises the nucleotide sequence is shown in SEQ ID NO. 31.
79. The recombinant host according to claim 76 wherein said polynucleotide comprises a pesticidal portion of the nucleotide sequence is shown in SEQ ID NO. 35.
80. The recombinant host according to claim 76 wherein said nucleotide sequence is shown in SEQ ID NO. 35.
81. The recombinant host according to claim 76 wherein said polynucleotide comprises a pesticidal portion of the nucleotide sequence is shown in SEQ ID NO. 40.
82. The recombinant host according to claim 76 wherein said nucleotide sequence is shown in SEQ ID NO. 40.
83. The recombinant host according to claim 76 wherein said nucleotide sequence is shown in SEQ ID NO. 44.
84. A recombinant host that expresses a polynucleotide encoding a pesticidal toxin from a Bacillus thuringiensis isolate selected from the group consisting of PS149B1, having the identifying characteristics of NRRL B-21553; and PS167H2, having the identifying characteristics of NRRL B-21554.
85. The recombinant host according to claim 84 wherein said isolate is PS149B1, having the identifying characteristics of NRRL B-21553.
86. The recombinant host according to claim 84 wherein said isolate is PS167H2, having the identifying characteristics of NRRL B-21554.
87. The recombinant host according to claim 84 wherein said toxin is approximately 10-15 kDa.
88. The recombinant host according to claim 85 wherein said toxin is approximately 10-15 kDa.
89. The recombinant host according to claim 86 wherein said toxin is approximately 10-15 kDa.
90. A recombinant host that expresses a polynucleotide encoding an approximately 10-15 kDa pesticidal toxin from Bacillus thuringiensis isolate PS80 JJ1, having the identifying characteristics of NRRL B-18679.
91. A recombinant host transformed to express the polynucleotide of claim 11.
92. The recombinant host of claim 91 wherein said host is a plant.
93. The recombinant host of claim 46 wherein said host is a plant.
94. The recombinant host of claim 69 wherein said host is a plant.
95. The recombinant host of claim 76 wherein said host is a plant.
96. The recombinant host of claim 84 wherein said host is a plant.
97. The recombinant host of claim 90 wherein said host is a plant.
98. A transformed host cell expressing at least a first polynucleotide, which encodes a first polypeptide of approximately 10-15 kDa, and at least a second polynucleotide, which encodes a second polypeptide of approximately 40-50 kDa, wherein said first polynucleotide has at least one characteristic selected from the following group of characteristics:
(a) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 32;
(b) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 35;
(c) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 41;
(d) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 31;
(e) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 35;
(f) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 40;
(g) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 44;
(h) said polynucleotide encodes a toxin from PS80JJ1, having the identifying characteristics of NRRL B-18679;
(i) said polynucleotide encodes a toxin from PS149B1, having the identifying characteristics of NRRL B-21553; and
(j) said polynucleotide encodes a toxin from PS167H2, having the identifying characteristics of NRRL B-21554;
and wherein said second polynucleotide has at least one characteristic selected from the following group of characteristics:
(k) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 11;
(l) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 38;
(m) said polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 43;
(n) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 45;
(o) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 10;
(p) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 37;
(q) said polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 42;
(r) said polynucleotide encodes a toxin from PS80JJ1, having the identifying characteristics of NRRL B-18679;
(s) said polynucleotide encodes a toxin from PS149B1, having the identifying characteristics of NRRL B-21553; and
(t) said polynucleotide encodes a toxin from PS167H2, having the identifying characteristics of NRRL B-21554.
99. The transformed host cell of claim 98 wherein said cell is a plant cell.
100. The cell according to claim 98 wherein said first polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 32.
101. The cell according to claim 98 wherein said first polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 36.
102. The cell according to claim 98 wherein said first polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 41.
103. The cell according to claim 98 wherein said first polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 31.
104. The cell according to claim 98 wherein said first polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 35.
105. The cell according to claim 98 wherein said first polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 40.
106. The cell according to claim 98 wherein said first polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 44.
107. The cell according to claim 98 wherein said first polynucleotide encodes a toxin from PS80JJ1, having the identifying characteristics of NRRL B-18679.
108. The cell according to claim 98 wherein said first polynucleotide encodes a toxin from PS149B1, having the identifying characteristics of NRRL B-21553.
109. The cell according to claim 98 wherein said first polynucleotide encodes a toxin from PS167H2, having the identifying characteristics of NRRL B-21554.
110. The cell according to claim 98 wherein said second polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 11.
111. The cell according to claim 98 wherein said second polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 38.
112. The cell according to claim 98 wherein said second polynucleotide encodes a polypeptide having an amino acid sequence shown in SEQ ID NO. 43.
113. The cell according to claim 98 wherein said second polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 45.
114. The cell according to claim 98 wherein said second polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 10.
115. The cell according to claim 98 wherein said second polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 37.
116. The cell according to claim 98 wherein said second polynucleotide comprises a nucleotide sequence shown in SEQ ID NO. 42.
117. The cell according to claim 98 wherein said second polynucleotide encodes a toxin from PS80JJ1, having the identifying characteristics of NRRL B-18679.
118. The cell according to claim 98 wherein said second polynucleotide encodes a toxin from PS149B1, having the identifying characteristics of NRRL B-21553.
119. The cell according to claim 98 wherein said second polynucleotide encodes a toxin from PS167H2, having the identifying characteristics of NRRL B-21554.

CROSS-REFERENCE TO A RELATED APPLICATION

This application is a continuation-in-part of application Ser. No. 08/633,993, filed Apr. 19, 1996, pending.

US Referenced Citations (10)

Number	Name	Date
4448885	Schnepf et al.	May 1984
4467036	Schnepf et al.	Aug 1984
4797276	Herrnstadt et al.	Jan 1989
4849217	Soares et al.	Jul 1989
4853331	Herrnstadt et al.	Aug 1989
4918006	Ellar et al.	Apr 1990
4948734	Edwards et al.	Aug 1990
5151363	Payne	Sep 1992
5204100	Carozzi et al.	Apr 1993
5208017	Bradfish et al.	May 1993

Foreign Referenced Citations (6)

Number	Date	Country
0359472	Mar 1990	EPX
454 485	Oct 1991	EPX
0462721	Dec 1991	EPX
9416079	Jul 1994	WOX
9416079	Jul 1994	WOX
9502694	Jan 1995	WOX

Non-Patent Literature Citations (8)

Entry
Beegle, C.C. (1978) "Use of Entomogenous Bacteria in Agroecosystems" Developments in Industrial Microbiologu 20:97-104.
Couch, T.L. (1980) "Mosquito Pathogenicity of Bacillus thuringiensis var. israelensis" Developments in Industrial Microbiology 22:61-76.
Feitelson, J.S. et al. (1992) "Bacillus thuringiensis: Insects and Beyond" Bio/Technology 10:271-275.
Gaertner, F.H. (1989) "Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms" Controlled Delivery of Crop-Protection Agents, pp. 245-257.
Gaertner, F., L. Kim (1988) "Current Applied Recombinant DNA Projects" Tibtech 6(4):S4-S7.
Hofte, H., H.R. Whiteley (1989) "Insecticidal Crystal Proteins of Bacillus thuringiensis" Microbiological Reviews 53(2):242-255.
Krieg, V.A. et al. (1983) "Bacillus thuringiensis var. tenebrionis: A New Pathotype Effective Against Larvae of Coleoptera" Z. ang. Ent. 96:500-508.
Schnepf, H.E., H.R. Whiteley (1981) "Cloning and expression of the Bacillus thuringiensis crystal protein gene in Escherichia coli" Proc. Natl. Acad. Sci. USA 78(5):2893-2897.

Continuation in Parts (1)

	Number	Date	Country
Parent	633993	Apr 1996

Pesticidal toxins

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications